p-menthane - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	p-menthane	go back to main search page
Accession:	CHEBI:25826	browse the term
Definition:	A monoterpene that has formula C10H20.
Synonyms:	related_synonym:	1-Methyl-4-(propan-2-yl)cyclohexane; 1-isopropyl-4-methylcyclohexane; 1-methyl-4-(1-methylethyl)-cyclohexane; Formula=C10H20; InChI=1S/C10H20/c1-8(2)10-6-4-9(3)5-7-10/h8-10H,4-7H2,1-3H3; InChIKey=CFJYNSNXFXLKNS-UHFFFAOYSA-N; SMILES=CC1CCC(CC1)C(C)C; p-Menthan; para-menthane
	xref:	Beilstein:1900617; CAS:99-82-1; LIPID_MAPS_instance:LMPR0102090000

show annotations for term's descendants Sort by:
Rat (825) Mouse (828) Human (851) Chinchilla (0) Bonobo (0) Dog (2) Squirrel (0) Pig (1) Green Monkey (0) Naked Mole-rat (0) All
Genes (851)

(-)-alpha-phellandrene

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

apoptosis antagonizing transcription factor

decreases expression

alpha phellandrene results in decreased expression of AATF mRNA

NCBI chr17:36,948,954...37,056,871
Ensembl chr17:36,948,925...37,056,871

G

acid phosphatase 1

decreases expression

alpha phellandrene results in decreased expression of ACP1 mRNA

NCBI chr 2:264,947...278,283
Ensembl chr 2:264,140...278,283

G

acyl-CoA synthetase short chain family member 2

increases expression

alpha phellandrene results in increased expression of ACSS2 mRNA

NCBI chr20:34,874,989...34,927,959
Ensembl chr20:34,872,146...34,927,962

G

ADAM metallopeptidase domain 18

decreases expression

alpha phellandrene results in decreased expression of ADAM18 mRNA

NCBI chr 8:39,584,568...39,730,065
Ensembl chr 8:39,584,489...39,730,065

G

ADAM metallopeptidase domain 3A (pseudogene)

decreases expression

alpha phellandrene results in decreased expression of ADAM3 mRNA

NCBI chr 8:39,451,045...39,522,989
Ensembl chr 8:39,451,045...39,522,852
Ensembl chr 8:39,451,045...39,522,852

G

AFG2 AAA ATPase homolog A

decreases expression

alpha phellandrene results in decreased expression of AFG2A mRNA

NCBI chr 4:122,923,078...123,319,433
Ensembl chr 4:122,923,070...123,319,433

G

AKT serine/threonine kinase 1

decreases expression

alpha phellandrene results in decreased expression of AKT1 protein

NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759

G

aldehyde dehydrogenase 1 family member L2

increases expression

alpha phellandrene results in increased expression of ALDH1L2 mRNA

NCBI chr12:105,019,790...105,084,458
Ensembl chr12:105,019,784...105,107,643

G

aldolase, fructose-bisphosphate C

increases expression

alpha phellandrene results in increased expression of ALDOC mRNA

NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948

G

ankyrin repeat domain 49

decreases expression

alpha phellandrene results in decreased expression of ANKRD49 mRNA

NCBI chr11:94,493,984...94,499,578
Ensembl chr11:94,493,979...94,499,578

G

annexin A1

increases expression

alpha phellandrene results in increased expression of ANXA1 mRNA

NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,629

G

annexin A9

decreases expression

alpha phellandrene results in decreased expression of ANXA9 mRNA

NCBI chr 1:150,977,306...150,995,634
Ensembl chr 1:150,982,249...150,995,634

G

adaptor related protein complex 3 subunit mu 2

increases expression

alpha phellandrene results in increased expression of AP3M2 mRNA

NCBI chr 8:42,153,063...42,171,183
Ensembl chr 8:42,152,946...42,171,673

G

arginase 2

increases expression

alpha phellandrene results in increased expression of ARG2 mRNA

NCBI chr14:67,619,920...67,651,708
Ensembl chr14:67,619,920...67,651,708

G

Rho guanine nucleotide exchange factor 12

increases expression

alpha phellandrene results in increased expression of ARHGEF12 mRNA

NCBI chr11:120,336,413...120,489,937
Ensembl chr11:120,336,413...120,489,937

G

arylsulfatase family member K

decreases expression

alpha phellandrene results in decreased expression of ARSK mRNA

NCBI chr 5:95,555,101...95,605,102
Ensembl chr 5:95,555,101...95,605,102

G

aspartoacylase

increases expression

alpha phellandrene results in increased expression of ASPA mRNA

NCBI chr17:3,474,110...3,503,405
Ensembl chr17:3,472,374...3,503,405

G

activating transcription factor 3

increases expression

alpha phellandrene results in increased expression of ATF3 mRNA

NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777

G

BCL2 apoptosis regulator

increases phosphorylation

alpha phellandrene results in increased phosphorylation of BCL2 protein

NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128

G

beclin 1

increases phosphorylation

alpha phellandrene results in increased phosphorylation of BECN1 protein

NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350

G

Bcl2 modifying factor

increases expression

alpha phellandrene results in increased expression of BMF mRNA

NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892

G

BCL2 interacting protein 3

increases expression

alpha phellandrene results in increased expression of BNIP3 mRNA

NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967

G

biorientation of chromosomes in cell division 1

increases expression

alpha phellandrene results in increased expression of BOD1 mRNA

NCBI chr 5:173,607,145...173,616,650
Ensembl chr 5:173,607,145...173,616,659

G

BRCA1 DNA repair associated

decreases expression

alpha phellandrene results in decreased expression of BRCA1 protein

NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245

G

BTG anti-proliferation factor 2

increases expression

alpha phellandrene results in increased expression of BTG2 mRNA

NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602

G

C9orf72-SMCR8 complex subunit

increases expression

alpha phellandrene results in increased expression of C9ORF72 mRNA

NCBI chr 9:27,546,546...27,573,866
Ensembl chr 9:27,535,640...27,573,866

G

calmodulin 2

increases expression

alpha phellandrene results in increased expression of CALM2 mRNA

NCBI chr 2:47,160,082...47,176,936
Ensembl chr 2:47,160,084...47,176,921

G

calpain small subunit 1

increases expression

alpha phellandrene results in increased expression of CAPNS1 mRNA

NCBI chr19:36,140,066...36,150,353
Ensembl chr19:36,139,953...36,150,353

G

caprin family member 2

increases expression

alpha phellandrene results in increased expression of CAPRIN2 mRNA

NCBI chr12:30,709,553...30,754,951
Ensembl chr12:30,709,552...30,823,302

G

caspase recruitment domain family member 6

increases expression

alpha phellandrene results in increased expression of CARD6 mRNA

NCBI chr 5:40,841,367...40,855,354
Ensembl chr 5:40,841,308...40,860,175

G

calcium regulated heat stable protein 1

increases expression

alpha phellandrene results in increased expression of CARHSP1 mRNA

NCBI chr16:8,852,942...8,869,006
Ensembl chr16:8,852,942...8,869,012

G

C-C motif chemokine ligand 5

increases expression

alpha phellandrene results in increased expression of CCL5 mRNA

NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793

G

cyclin G2

increases expression

alpha phellandrene results in increased expression of CCNG2 mRNA

NCBI chr 4:77,157,207...77,170,060
Ensembl chr 4:77,157,207...77,433,388

G

C-C motif chemokine receptor like 2

increases expression

alpha phellandrene results in increased expression of CCRL2 mRNA

NCBI chr 3:46,407,259...46,409,523
Ensembl chr 3:46,407,166...46,412,997

G

CD59 molecule (CD59 blood group)

decreases expression

alpha phellandrene results in decreased expression of CD59A mRNA

NCBI chr11:33,703,010...33,736,479
Ensembl chr11:33,703,010...33,736,479

G

CUB domain containing protein 2

increases expression

alpha phellandrene results in increased expression of CDCP2 mRNA

NCBI chr 1:54,132,687...54,153,000
Ensembl chr 1:54,132,687...54,153,770

G

cyclin dependent kinase inhibitor 1A

increases expression

alpha phellandrene results in increased expression of CDKN1A mRNA

NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397

G

cyclin dependent kinase inhibitor 2D

increases expression

alpha phellandrene results in increased expression of CDKN2D mRNA

NCBI chr19:10,566,460...10,568,979
Ensembl chr19:10,566,460...10,569,059

G

CASP8 and FADD like apoptosis regulator

increases expression

alpha phellandrene results in increased expression of CFLAR mRNA

NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687

G

C-type lectin domain family 12 member A

decreases expression

alpha phellandrene results in decreased expression of CLEC12A mRNA

NCBI chr12:9,951,268...10,006,150
Ensembl chr12:9,951,316...9,995,694

G

C-type lectin domain family 4 member D

decreases expression

alpha phellandrene results in decreased expression of CLEC4D mRNA

NCBI chr12:8,513,503...8,531,696
Ensembl chr12:8,509,475...8,522,366

G

C-type lectin domain containing 6A

decreases expression

alpha phellandrene results in decreased expression of CLEC4N mRNA

NCBI chr12:8,455,962...8,478,330
Ensembl chr12:8,455,962...8,478,330

G

clustered mitochondria homolog

decreases expression

alpha phellandrene results in decreased expression of CLUH mRNA

NCBI chr17:2,689,387...2,712,020
Ensembl chr17:2,689,386...2,712,663

G

cytidine/uridine monophosphate kinase 2

increases expression

alpha phellandrene results in increased expression of CMPK2 mRNA

NCBI chr 2:6,840,553...6,866,635
Ensembl chr 2:6,840,570...6,866,635

G

complement C3b/C4b receptor 1 like

decreases expression

alpha phellandrene results in decreased expression of CR1L mRNA

NCBI chr 1:207,645,133...207,723,703
Ensembl chr 1:207,645,113...207,738,416

G

cysteine rich secretory protein 1

decreases expression

alpha phellandrene results in decreased expression of CRISP1 mRNA

NCBI chr 6:49,834,257...49,877,096
Ensembl chr 6:49,834,257...49,877,096

G

cystatin F

decreases expression

alpha phellandrene results in decreased expression of CST7 mRNA

NCBI chr20:24,949,269...24,959,928
Ensembl chr20:24,949,269...24,959,928

G

cystatin A

increases expression

alpha phellandrene results in increased expression of STFA1 mRNA

NCBI chr 3:122,325,248...122,341,969
Ensembl chr 3:122,325,248...122,341,969

G

cathepsin G

decreases expression

alpha phellandrene results in decreased expression of CTSG mRNA

NCBI chr14:24,573,518...24,576,250
Ensembl chr14:24,573,518...24,576,250

G

C-X-C motif chemokine ligand 10

increases expression

alpha phellandrene results in increased expression of CXCL10 mRNA

NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497

G

cytochrome b561 family member D2

decreases expression

alpha phellandrene results in decreased expression of CYB561D2 mRNA

NCBI chr 3:50,350,862...50,354,069
Ensembl chr 3:50,350,845...50,358,460

G

cytoplasmic FMR1 interacting protein 2

increases expression

alpha phellandrene results in increased expression of CYFIP2 mRNA

NCBI chr 5:157,266,123...157,395,594
Ensembl chr 5:157,266,079...157,395,595

G

cytochrome P450 family 51 subfamily A member 1

decreases expression

alpha phellandrene results in decreased expression of CYP51 mRNA

NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803

G

developing brain homeobox 1

increases expression

alpha phellandrene results in increased expression of DBX1 mRNA

NCBI chr11:20,156,155...20,160,475
Ensembl chr11:20,156,155...20,160,475

G

dCMP deaminase

decreases expression

alpha phellandrene results in decreased expression of DCTD mRNA

NCBI chr 4:182,890,091...182,917,611
Ensembl chr 4:182,890,060...182,917,936

G

DNA damage inducible transcript 4

increases expression

alpha phellandrene results in increased expression of DDIT4 mRNA

NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036

G

DEAD-box helicase 31

decreases expression

alpha phellandrene results in decreased expression of DDX31 mRNA

NCBI chr 9:132,592,997...132,669,983
Ensembl chr 9:132,592,997...132,670,401

G

DExD/H-box helicase 60

increases expression

alpha phellandrene results in increased expression of DDX60 mRNA

NCBI chr 4:168,216,294...168,325,979
Ensembl chr 4:168,216,291...168,318,883

G

DNA fragmentation factor subunit beta

increases expression

alpha phellandrene results in increased expression of DFFB mRNA

NCBI chr 1:3,857,476...3,885,429
Ensembl chr 1:3,857,267...3,885,429

G

diacylglycerol kinase alpha

increases expression

alpha phellandrene results in increased expression of DGKA mRNA

NCBI chr12:55,927,316...55,954,023
Ensembl chr12:55,927,319...55,954,027

G

dehydrogenase/reductase 1

increases expression

alpha phellandrene results in increased expression of DHRS1 mRNA

NCBI chr14:24,290,598...24,299,780
Ensembl chr14:24,290,598...24,299,780

G

DEAH-box helicase 33

decreases expression

alpha phellandrene results in decreased expression of DHX33 mRNA

NCBI chr17:5,440,917...5,468,982
Ensembl chr17:5,440,917...5,468,982

G

DExH-box helicase 58

increases expression

alpha phellandrene results in increased expression of DHX58 mRNA

NCBI chr17:42,101,411...42,112,714
Ensembl chr17:42,101,404...42,112,714

G

dyskerin pseudouridine synthase 1

decreases expression

alpha phellandrene results in decreased expression of DKC1 mRNA

NCBI chr X:154,762,864...154,777,689
Ensembl chr X:154,762,742...154,777,689

G

dual specificity phosphatase 1

increases expression

alpha phellandrene results in increased expression of DUSP1 mRNA

NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195

G

dual specificity phosphatase 6

increases expression

alpha phellandrene results in increased expression of DUSP6 mRNA

NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501

G

dynein light chain Tctex-type 3

increases expression

alpha phellandrene results in increased expression of DYNLT3 mRNA

NCBI chr X:37,838,836...37,847,571
Ensembl chr X:37,836,757...37,847,571

G

egl-9 family hypoxia inducible factor 3

increases expression

alpha phellandrene results in increased expression of EGLN3 mRNA

NCBI chr14:33,924,227...33,951,074
Ensembl chr14:33,924,227...34,462,774

G

early growth response 1

increases expression

alpha phellandrene results in increased expression of EGR1 mRNA

NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303

G

eukaryotic translation initiation factor 5

decreases expression

alpha phellandrene results in decreased expression of EIF5 mRNA

NCBI chr14:103,334,237...103,345,025
Ensembl chr14:103,333,544...103,345,025

G

elaC ribonuclease Z 2

decreases expression

alpha phellandrene results in decreased expression of ELAC2 mRNA

NCBI chr17:12,991,612...13,018,027
Ensembl chr17:12,991,612...13,018,065

G

ELOVL fatty acid elongase 1

decreases expression

alpha phellandrene results in decreased expression of ELOVL1 mRNA

NCBI chr 1:43,363,401...43,368,011
Ensembl chr 1:43,363,398...43,368,074

G

ELOVL fatty acid elongase 7

increases expression

alpha phellandrene results in increased expression of ELOVL7 mRNA

NCBI chr 5:60,751,791...60,844,269
Ensembl chr 5:60,751,791...60,844,274

G

enolase 2

increases expression

alpha phellandrene results in increased expression of ENO2 mRNA

NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698

G

F-box protein 44

increases expression

alpha phellandrene results in increased expression of FBXO44 mRNA

NCBI chr 1:11,654,407...11,663,327
Ensembl chr 1:11,654,375...11,663,327

G

FGGY carbohydrate kinase domain containing

increases expression

alpha phellandrene results in increased expression of FGGY mRNA

NCBI chr 1:59,296,378...59,762,730
Ensembl chr 1:59,296,638...59,810,647

G

FLVCR choline and heme transporter 1

decreases expression

alpha phellandrene results in decreased expression of FLVCR1 mRNA

NCBI chr 1:212,858,275...212,899,363
Ensembl chr 1:212,858,275...212,899,363

G

Fos proto-oncogene, AP-1 transcription factor subunit

increases expression

alpha phellandrene results in increased expression of FOS mRNA

NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190

G

forkhead box O1

increases expression

alpha phellandrene results in increased expression of FOXO1 mRNA

NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641

G

formyl peptide receptor 1

decreases expression

alpha phellandrene results in decreased expression of FPR1 mRNA

NCBI chr19:51,745,172...51,751,878
Ensembl chr19:51,745,172...51,804,115

G

ferritin heavy chain 1

increases expression

alpha phellandrene results in increased expression of FTH1 mRNA

NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634

G

ferritin light chain

increases expression

alpha phellandrene results in increased expression of FTL1 mRNA; alpha phellandrene results in increased expression of FTL2-PS mRNA

NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,967,896

G

FtsJ RNA 2'-O-methyltransferase 3

decreases expression

alpha phellandrene results in decreased expression of FTSJ3 mRNA

NCBI chr17:63,819,433...63,827,663
Ensembl chr17:63,819,433...63,830,012

G

frataxin

decreases expression

alpha phellandrene results in decreased expression of FXN mRNA

NCBI chr 9:69,035,752...69,079,076
Ensembl chr 9:69,035,751...69,079,076

G

GABA type A receptor-associated protein

increases expression

alpha phellandrene results in increased expression of GABARAP mRNA

NCBI chr17:7,240,008...7,242,449
Ensembl chr17:7,240,008...7,242,449

G

growth arrest and DNA damage inducible alpha

increases expression

alpha phellandrene results in increased expression of GADD45A mRNA

NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334

G

growth arrest specific 5

decreases expression

alpha phellandrene results in decreased expression of GAS5 mRNA

NCBI chr 1:173,863,901...173,869,045
Ensembl chr 1:173,851,424...173,868,940

G

guanylate binding protein family member 6

increases expression

alpha phellandrene results in increased expression of GBP6 mRNA

NCBI chr 1:89,364,059...89,388,160
Ensembl chr 1:89,364,059...89,388,160

G

GNAS complex locus

increases expression

alpha phellandrene results in increased expression of GNAS mRNA

NCBI chr20:58,839,748...58,911,192
Ensembl chr20:58,839,718...58,911,192

G

G protein nucleolar 3

decreases expression

alpha phellandrene results in decreased expression of GNL3 mRNA

NCBI chr 3:52,685,920...52,694,497
Ensembl chr 3:52,681,156...52,694,497

G

G protein-coupled receptor 84

decreases expression

alpha phellandrene results in decreased expression of GPR84 mRNA

NCBI chr12:54,350,698...54,364,486
Ensembl chr12:54,362,445...54,364,487

G

GREB1 like retinoic acid receptor coactivator

increases expression

alpha phellandrene results in increased expression of GREB1L mRNA

NCBI chr18:21,242,232...21,526,112
Ensembl chr18:21,242,232...21,526,112

G

glutamate ionotropic receptor NMDA type subunit associated protein 1

increases expression

alpha phellandrene results in increased expression of GRINA mRNA

NCBI chr 8:143,990,056...143,993,415
Ensembl chr 8:143,990,056...143,993,415

G

glycosyltransferase like domain containing 1

increases expression

alpha phellandrene results in increased expression of GTDC1 mRNA

NCBI chr 2:143,938,068...144,333,069
Ensembl chr 2:143,938,068...144,332,568

G

glycogen synthase 1

increases expression

alpha phellandrene results in increased expression of GYS1 mRNA

NCBI chr19:48,968,130...48,993,309
Ensembl chr19:48,968,130...48,993,310

G

granzyme H

decreases expression

alpha phellandrene results in decreased expression of GZME mRNA

NCBI chr14:24,606,480...24,609,685
Ensembl chr14:24,606,480...24,609,699

G

H1.0 linker histone

increases expression

alpha phellandrene results in increased expression of H1F0 mRNA

NCBI chr22:37,805,229...37,807,432
Ensembl chr22:37,805,229...37,807,432

G

H1.2 linker histone, cluster member

increases expression

alpha phellandrene results in increased expression of H1F2 mRNA

NCBI chr 6:26,055,740...26,056,470
Ensembl chr 6:26,054,760...26,056,470

G

H2B clustered histone 14

increases expression

alpha phellandrene results in increased expression of H2BC14 mRNA

NCBI chr 6:27,815,022...27,815,489
Ensembl chr 6:27,815,022...27,815,489

G

H2B clustered histone 18

increases expression

alpha phellandrene results in increased expression of H2BC18 mRNA

NCBI chr 1:149,782,689...149,812,370
Ensembl chr 1:149,782,689...149,812,373

G

H2B clustered histone 4

increases expression

alpha phellandrene results in increased expression of H2BC4 mRNA

NCBI chr 6:26,113,170...26,123,926
Ensembl chr 6:26,086,317...26,123,926

G

H3 clustered histone 4

increases expression

alpha phellandrene results in increased expression of H3C4 mRNA

NCBI chr 6:26,196,784...26,199,293
Ensembl chr 6:26,195,164...26,197,286

G

H4 clustered histone 4

increases expression

alpha phellandrene results in increased expression of H4C4 mRNA

NCBI chr 6:26,188,710...26,189,112
Ensembl chr 6:26,188,710...26,189,112

G

hydroxycarboxylic acid receptor 2

increases expression

alpha phellandrene results in increased expression of HCAR2 mRNA

NCBI chr12:122,701,293...122,703,357
Ensembl chr12:122,701,293...122,703,357

G

HEAT repeat containing 1

decreases expression

alpha phellandrene results in decreased expression of HEATR1 mRNA

NCBI chr 1:236,549,005...236,604,516
Ensembl chr 1:236,549,005...236,604,516

G

helicase with zinc finger 2

increases expression

alpha phellandrene results in increased expression of HELZ2 mRNA

NCBI chr20:63,558,086...63,574,239
Ensembl chr20:63,558,086...63,574,239

G

HGH1 homolog

decreases expression

alpha phellandrene results in decreased expression of BRP16 mRNA

NCBI chr 8:144,137,774...144,140,851
Ensembl chr 8:144,137,774...144,140,851

G

hypoxia inducible lipid droplet associated

increases expression

alpha phellandrene results in increased expression of HILPDA mRNA

NCBI chr 7:128,455,878...128,458,418
Ensembl chr 7:128,455,849...128,458,418

G

HIVEP zinc finger 3

increases expression

alpha phellandrene results in increased expression of HIVEP3 mRNA

NCBI chr 1:41,506,365...42,035,934
Ensembl chr 1:41,506,365...42,035,925

G

heat shock protein family A (Hsp70) member 2

increases expression

alpha phellandrene results in increased expression of HSPA2 mRNA

NCBI chr14:64,535,905...64,543,237
Ensembl chr14:64,535,905...64,546,173

G

heat shock protein family A (Hsp70) member 5

decreases expression

alpha phellandrene results in decreased expression of HSPA5 mRNA

NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382

G

heat shock protein family A (Hsp70) member 8

decreases expression

alpha phellandrene results in decreased expression of HSPA8 mRNA

NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230

G

inhibitor of DNA binding 2

increases expression

alpha phellandrene results in increased expression of ID2 mRNA

NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461

G

isopentenyl-diphosphate delta isomerase 1

decreases expression

alpha phellandrene results in decreased expression of IDI1 mRNA

NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119

G

interferon induced with helicase C domain 1

increases expression

alpha phellandrene results in increased expression of IFIH1 mRNA

NCBI chr 2:162,267,074...162,318,684
Ensembl chr 2:162,267,074...162,318,684

G

interferon induced protein with tetratricopeptide repeats 1

increases expression

alpha phellandrene results in increased expression of IFIT1 mRNA

NCBI chr10:89,392,623...89,406,487
Ensembl chr10:89,392,546...89,406,487

G

interferon lambda 3

increases expression

alpha phellandrene results in increased expression of IFNL3 mRNA

NCBI chr19:39,243,455...39,245,250
Ensembl chr19:39,243,455...39,245,250

G

interleukin 2 receptor subunit alpha

decreases expression

alpha phellandrene results in decreased expression of IL2RA mRNA

NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370

G

interleukin 36 gamma

decreases expression

alpha phellandrene results in decreased expression of IL36G mRNA

NCBI chr 2:112,978,006...112,985,658
Ensembl chr 2:112,973,203...112,985,658

G

interferon regulatory factor 5

increases expression

alpha phellandrene results in increased expression of IRF5 mRNA

NCBI chr 7:128,937,032...128,950,038
Ensembl chr 7:128,937,457...128,950,038

G

interferon regulatory factor 7

increases expression

alpha phellandrene results in increased expression of IRF7 mRNA

NCBI chr11:612,555...615,950
Ensembl chr11:612,553...615,983

G

immunity related GTPase M

increases expression

alpha phellandrene results in increased expression of IRGM2 mRNA

NCBI chr 5:150,846,521...150,902,402
Ensembl chr 5:150,846,521...150,900,736

G

integrin subunit alpha L

increases expression

alpha phellandrene results in increased expression of ITGAL mRNA

NCBI chr16:30,472,742...30,523,185
Ensembl chr16:30,472,658...30,523,567

G

jagunal homolog 1

decreases expression

alpha phellandrene results in decreased expression of JAGN1 mRNA

NCBI chr 3:9,890,610...9,894,349
Ensembl chr 3:9,890,574...9,894,349

G

Jun proto-oncogene, AP-1 transcription factor subunit

increases expression

alpha phellandrene results in increased expression of JUN mRNA

NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048

G

KN motif and ankyrin repeat domains 2

decreases expression

alpha phellandrene results in decreased expression of KANK2 mRNA

NCBI chr19:11,164,270...11,197,865
Ensembl chr19:11,164,270...11,197,791

G

lysine demethylase 7A

increases expression

alpha phellandrene results in increased expression of KDM7A mRNA

NCBI chr 7:140,084,746...140,176,983
Ensembl chr 7:140,084,746...140,176,983

G

kelch like family member 23

increases expression

alpha phellandrene results in increased expression of KLHL23 mRNA

NCBI chr 2:169,733,832...169,751,878
Ensembl chr 2:169,694,488...169,776,989

G

kelch like family member 24

increases expression

alpha phellandrene results in increased expression of KLHL24 mRNA

NCBI chr 3:183,635,623...183,684,519
Ensembl chr 3:183,635,610...183,684,519

G

LIM domain and actin binding 1

increases expression

alpha phellandrene results in increased expression of LIMA1 mRNA

NCBI chr12:50,175,788...50,283,520
Ensembl chr12:50,175,788...50,283,520

G

LLGL scribble cell polarity complex component 2

decreases expression

alpha phellandrene results in decreased expression of LLGL2 mRNA

NCBI chr17:75,525,002...75,575,209
Ensembl chr17:75,525,080...75,575,209

G

LIM domain containing preferred translocation partner in lipoma

increases expression

alpha phellandrene results in increased expression of LPP mRNA

NCBI chr 3:188,153,021...188,890,671
Ensembl chr 3:188,153,284...188,890,671

G

listerin E3 ubiquitin protein ligase 1

decreases expression

alpha phellandrene results in decreased expression of LTN1 mRNA

NCBI chr21:28,928,144...28,992,877
Ensembl chr21:28,928,144...28,992,956

G

lymphocyte antigen 6 family member H

decreases expression

alpha phellandrene results in decreased expression of LY6C1 mRNA; alpha phellandrene results in decreased expression of LY6C2 mRNA

NCBI chr 8:143,157,916...143,160,654
Ensembl chr 8:143,157,914...143,160,711

G

mitogen-activated protein kinase kinase 6

increases expression

alpha phellandrene results in increased expression of MAP2K6 mRNA

NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,697...69,553,865

G

methionine adenosyltransferase 2A

decreases expression

alpha phellandrene results in decreased expression of MAT2A mRNA

NCBI chr 2:85,539,168...85,545,281
Ensembl chr 2:85,539,168...85,545,281

G

mast cell expressed membrane protein 1

increases expression

alpha phellandrene results in increased expression of MCEMP1 mRNA

NCBI chr19:7,677,090...7,679,829
Ensembl chr19:7,677,088...7,679,829

G

mediator of DNA damage checkpoint 1

increases expression

alpha phellandrene results in increased expression of MDC1 protein

NCBI chr 6:30,699,807...30,717,281
Ensembl chr 6:30,699,807...30,717,447

G

midasin AAA ATPase 1

decreases expression

alpha phellandrene results in decreased expression of MDN1 mRNA

NCBI chr 6:89,642,498...89,819,794
Ensembl chr 6:89,642,498...89,819,794

G

mediator complex subunit 29

decreases expression

alpha phellandrene results in decreased expression of MED29 mRNA

NCBI chr19:39,391,378...39,400,641
Ensembl chr19:39,391,303...39,400,641

G

mediator complex subunit 31

increases expression

alpha phellandrene results in increased expression of MED31 mRNA

NCBI chr17:6,643,311...6,651,605
Ensembl chr17:6,643,311...6,651,634

G

mitochondria localized glutamic acid rich protein

increases expression

alpha phellandrene results in increased expression of MGARP mRNA

NCBI chr 4:139,266,165...139,280,225
Ensembl chr 4:139,266,165...139,280,225

G

alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase

decreases expression

alpha phellandrene results in decreased expression of MGAT2 mRNA

NCBI chr14:49,620,799...49,623,481
Ensembl chr14:49,620,799...49,623,481

G

O-6-methylguanine-DNA methyltransferase

decreases expression

alpha phellandrene results in decreased expression of MGMT protein

NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983

G

MINDY lysine 48 deubiquitinase 2

increases expression

alpha phellandrene results in increased expression of MINDY2 mRNA

NCBI chr15:58,771,302...58,861,900
Ensembl chr15:58,771,192...58,861,900

G

miR-17-92a-1 cluster host gene

decreases expression

alpha phellandrene results in decreased expression of MIR17HG mRNA

NCBI chr13:91,347,687...91,354,577
Ensembl chr13:91,347,686...91,397,592

G

microRNA 375

increases expression

alpha phellandrene results in increased expression of MIR375 mRNA

NCBI chr 2:219,001,645...219,001,708
Ensembl chr 2:219,001,645...219,001,708

G

major histocompatibility complex, class I-related

increases expression

alpha phellandrene results in increased expression of MR1 mRNA

NCBI chr 1:181,033,387...181,061,938
Ensembl chr 1:181,033,374...181,061,938

G

mitochondrial ribosomal protein L20

decreases expression

alpha phellandrene results in decreased expression of MRPL20 mRNA

NCBI chr 1:1,401,909...1,407,293
Ensembl chr 1:1,401,909...1,407,293

G

mitochondrial ribosomal protein L45

increases expression

alpha phellandrene results in increased expression of MRPL45 mRNA

NCBI chr17:38,297,168...38,323,211
Ensembl chr17:38,297,023...38,323,217

G

MRT4 homolog, ribosome maturation factor

decreases expression

alpha phellandrene results in decreased expression of MRTO4 mRNA

NCBI chr 1:19,251,805...19,260,128
Ensembl chr 1:19,251,805...19,260,128

G

membrane spanning 4-domains A3

decreases expression

alpha phellandrene results in decreased expression of MS4A3 mRNA

NCBI chr11:60,056,665...60,071,115
Ensembl chr11:60,056,587...60,071,115

G

mechanistic target of rapamycin kinase

decreases expression

alpha phellandrene results in decreased expression of MTOR protein

NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556

G

metaxin 3

decreases expression

alpha phellandrene results in decreased expression of MTX3 mRNA

NCBI chr 5:79,976,716...79,991,262
Ensembl chr 5:79,976,716...79,991,262

G

mucin 13, cell surface associated

decreases expression

alpha phellandrene results in decreased expression of MUC13 mRNA

NCBI chr 3:124,905,442...124,934,751
Ensembl chr 3:124,905,442...124,953,819

G

MX dynamin like GTPase 2

increases expression

alpha phellandrene results in increased expression of MX2 mRNA

NCBI chr21:41,362,027...41,409,393
Ensembl chr21:41,361,999...41,409,393

G

MAX dimerization protein 1

increases expression

alpha phellandrene results in increased expression of MXD1 mRNA

NCBI chr 2:69,915,109...69,942,945
Ensembl chr 2:69,897,688...69,942,945

G

myeloid associated differentiation marker

increases expression

alpha phellandrene results in increased expression of MYADM mRNA

NCBI chr19:53,865,628...53,876,435
Ensembl chr19:53,864,763...53,878,125

G

MYB binding protein 1a

decreases expression

alpha phellandrene results in decreased expression of MYBBP1A mRNA

NCBI chr17:4,538,904...4,555,384
Ensembl chr17:4,538,897...4,555,386

G

myosin IXA

increases expression

alpha phellandrene results in increased expression of MYO9A mRNA

NCBI chr15:71,822,291...72,118,600
Ensembl chr15:71,822,291...72,118,577

G

nicotinamide phosphoribosyltransferase

increases expression

alpha phellandrene results in increased expression of NAMPT mRNA

NCBI chr 7:106,248,298...106,285,888
Ensembl chr 7:106,248,298...106,285,966

G

N-acetyltransferase 10

decreases expression

alpha phellandrene results in decreased expression of NAT10 mRNA

NCBI chr11:34,105,629...34,146,908
Ensembl chr11:34,105,617...34,147,670

G

NDRG family member 2

increases expression

alpha phellandrene results in increased expression of NDRG2 mRNA

NCBI chr14:21,016,763...21,070,872
Ensembl chr14:21,016,763...21,070,872

G

nuclear factor, interleukin 3 regulated

increases expression

alpha phellandrene results in increased expression of NFIL3 mRNA

NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,408,748...91,424,626

G

NFKB inhibitor alpha

increases expression

alpha phellandrene results in increased expression of NFKBIA mRNA

NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749

G

NHP2 ribonucleoprotein

decreases expression

alpha phellandrene results in decreased expression of NHP2 mRNA

NCBI chr 5:178,149,463...178,153,885
Ensembl chr 5:178,149,463...178,153,894

G

nucleolar protein 10

decreases expression

alpha phellandrene results in decreased expression of NOL10 mRNA

NCBI chr 2:10,570,754...10,689,975
Ensembl chr 2:10,562,347...10,689,987

G

nucleolar protein 8

decreases expression

alpha phellandrene results in decreased expression of NOL8 mRNA

NCBI chr 9:92,297,358...92,325,350
Ensembl chr 9:92,297,358...92,325,636

G

nucleolar and coiled-body phosphoprotein 1

decreases expression

alpha phellandrene results in decreased expression of NOLC1 mRNA

NCBI chr10:102,152,389...102,163,870
Ensembl chr10:102,152,176...102,163,871

G

NOP2 nucleolar protein

decreases expression

alpha phellandrene results in decreased expression of NOP2 mRNA

NCBI chr12:6,556,871...6,568,291
Ensembl chr12:6,556,863...6,568,691

G

NOP56 ribonucleoprotein

decreases expression

alpha phellandrene results in decreased expression of NOP56 mRNA

NCBI chr20:2,652,632...2,658,393
Ensembl chr20:2,652,593...2,658,393

G

nitric oxide synthase 2

increases expression

alpha phellandrene results in increased expression of NOS2 mRNA

NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529

G

nuclear transport factor 2 like export factor 2

increases expression

alpha phellandrene results in increased expression of NXT2 mRNA

NCBI chr X:109,535,824...109,544,698
Ensembl chr X:109,535,781...109,544,698

G

2'-5'-oligoadenylate synthetase 1

increases expression

alpha phellandrene results in increased expression of OAS1A mRNA; alpha phellandrene results in increased expression of OAS1B mRNA

NCBI chr12:112,906,962...112,933,219
Ensembl chr12:112,905,856...112,933,219

G

2'-5'-oligoadenylate synthetase 3

increases expression

alpha phellandrene results in increased expression of OAS3 mRNA

NCBI chr12:112,938,474...112,973,251
Ensembl chr12:112,938,051...112,976,460

G

oxysterol binding protein like 9

increases expression

alpha phellandrene results in increased expression of OSBPL9 mRNA

NCBI chr 1:51,518,272...51,789,219
Ensembl chr 1:51,577,179...51,798,427

G

PABIR family member 2

increases expression

alpha phellandrene results in increased expression of PABIR2 mRNA

NCBI chr X:134,769,566...134,797,205
Ensembl chr X:134,769,566...134,797,232

G

poly(ADP-ribose) polymerase family member 14

increases expression

alpha phellandrene results in increased expression of PARP14 mRNA

NCBI chr 3:122,680,839...122,730,840
Ensembl chr 3:122,680,839...122,730,840

G

prenylcysteine oxidase 1 like

decreases expression

alpha phellandrene results in decreased expression of PCYOX1L mRNA

NCBI chr 5:149,358,046...149,369,653
Ensembl chr 5:149,358,037...149,369,653

G

phosphodiesterase 3B

increases expression

alpha phellandrene results in increased expression of PDE3B mRNA

NCBI chr11:14,643,804...14,899,321
Ensembl chr11:14,643,804...14,872,044

G

phosphoethanolamine/phosphocholine phosphatase 1

increases expression

alpha phellandrene results in increased expression of PHOSPHO1 mRNA

NCBI chr17:49,223,366...49,230,787
Ensembl chr17:49,223,366...49,230,787

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta

increases expression

alpha phellandrene results in increased expression of PIK3CB mRNA

NCBI chr 3:138,652,698...138,834,928
Ensembl chr 3:138,652,336...138,834,928

G

phospholipase D family member 4

increases expression

alpha phellandrene results in increased expression of PLD4 mRNA

NCBI chr14:104,924,879...104,937,785
Ensembl chr14:104,924,713...104,937,761

G

plexin domain containing 1

increases expression

alpha phellandrene results in increased expression of PLXDC1 mRNA

NCBI chr17:39,063,313...39,152,967
Ensembl chr17:39,063,313...39,154,394

G

proline rich nuclear receptor coactivator 2

increases expression

alpha phellandrene results in increased expression of PNRC2 mRNA

NCBI chr 1:23,959,164...23,963,462
Ensembl chr 1:23,956,839...23,963,462

G

RNA polymerase I subunit B

decreases expression

alpha phellandrene results in decreased expression of POLR1B mRNA

NCBI chr 2:112,542,036...112,579,818
Ensembl chr 2:112,541,915...112,579,818

G

POP1 homolog, ribonuclease P/MRP subunit

decreases expression

alpha phellandrene results in decreased expression of POP1 mRNA

NCBI chr 8:98,117,293...98,159,835
Ensembl chr 8:98,117,293...98,159,835

G

peter pan homolog

decreases expression

alpha phellandrene results in decreased expression of PPAN mRNA

NCBI chr19:10,106,223...10,112,012
Ensembl chr19:10,106,362...10,112,012

G

phosphoribosyl pyrophosphate amidotransferase

decreases expression

alpha phellandrene results in decreased expression of PPAT mRNA

NCBI chr 4:56,393,362...56,435,615
Ensembl chr 4:56,393,362...56,435,615

G

protein phosphatase, Mg2+/Mn2+ dependent 1K

increases expression

alpha phellandrene results in increased expression of PPM1K mRNA

NCBI chr 4:88,257,620...88,284,561
Ensembl chr 4:88,257,620...88,284,769

G

protein phosphatase 2 regulatory subunit B'gamma

increases expression

alpha phellandrene results in increased expression of PPP2R5C mRNA

NCBI chr14:101,760,573...101,927,992
Ensembl chr14:101,761,709...101,927,989

G

PPARG related coactivator 1

decreases expression

alpha phellandrene results in decreased expression of PPRC1 mRNA

NCBI chr10:102,119,889...102,150,333
Ensembl chr10:102,132,994...102,150,333

G

protein kinase, DNA-activated, catalytic subunit

decreases expression

alpha phellandrene results in decreased expression of PRKDC protein

NCBI chr 8:47,773,111...47,960,136
Ensembl chr 8:47,773,111...47,960,178

G

serine protease 1

decreases expression

alpha phellandrene results in decreased expression of TRY10 mRNA

NCBI chr 7:142,749,472...142,753,072
Ensembl chr 7:142,749,468...142,753,072

G

polypyrimidine tract binding protein 3

increases expression

alpha phellandrene results in increased expression of PTBP3 mRNA

NCBI chr 9:112,217,715...112,379,882
Ensembl chr 9:112,217,716...112,333,664

G

protein tyrosine phosphatase mitochondrial 1

decreases expression

alpha phellandrene results in decreased expression of PTPMT1 mRNA

NCBI chr11:47,565,599...47,573,461
Ensembl chr11:47,565,430...47,573,461

G

protein tyrosine phosphatase non-receptor type 7

decreases expression

alpha phellandrene results in decreased expression of PTPN7 mRNA

NCBI chr 1:202,147,013...202,161,588
Ensembl chr 1:202,147,012...202,161,588

G

pseudouridine synthase 7

decreases expression

alpha phellandrene results in decreased expression of PUS7 mRNA

NCBI chr 7:105,456,501...105,522,271
Ensembl chr 7:105,439,661...105,522,271

G

pseudouridine synthase 7 like

decreases expression

alpha phellandrene results in decreased expression of PUS7L mRNA

NCBI chr12:43,718,992...43,758,790
Ensembl chr12:43,718,992...43,758,793

G

RAD51 paralog C

increases expression

alpha phellandrene results in increased expression of RAD51C mRNA

NCBI chr17:58,692,573...58,735,611
Ensembl chr17:58,692,573...58,735,611

G

RAP2B, member of RAS oncogene family

increases expression

alpha phellandrene results in increased expression of RAP2B mRNA

NCBI chr 3:153,162,226...153,170,627
Ensembl chr 3:153,162,226...153,170,627

G

RNA binding motif protein 12B

decreases expression

alpha phellandrene results in decreased expression of RBM12B2 mRNA

NCBI chr 8:93,728,155...93,741,009
Ensembl chr 8:93,728,155...93,741,017

G

recombination signal binding protein for immunoglobulin kappa J region

increases expression

alpha phellandrene results in increased expression of RBPJ mRNA

NCBI chr 4:26,105,449...26,435,131
Ensembl chr 4:26,163,455...26,435,131

G

RNA terminal phosphate cyclase like 1

decreases expression

alpha phellandrene results in decreased expression of RCL1 mRNA

NCBI chr 9:4,792,944...4,861,066
Ensembl chr 9:4,792,944...4,885,917

G

Rho related BTB domain containing 2

increases expression

alpha phellandrene results in increased expression of RHOBTB2 mRNA

NCBI chr 8:22,950,813...23,020,199
Ensembl chr 8:22,987,417...23,020,509

G

RNA sensor RIG-I

increases expression

alpha phellandrene results in increased expression of RIGI mRNA

NCBI chr 9:32,455,302...32,526,196
Ensembl chr 9:32,455,302...32,526,348

G

ring finger protein 141

increases expression

alpha phellandrene results in increased expression of RNF141 mRNA

NCBI chr11:10,511,673...10,541,187
Ensembl chr11:10,511,673...10,541,230

G

ring finger protein 19B

increases expression

alpha phellandrene results in increased expression of RNF19B mRNA

NCBI chr 1:32,929,036...32,964,809
Ensembl chr 1:32,936,445...32,964,809

G

RP2 activator of ARL3 GTPase

increases expression

alpha phellandrene results in increased expression of RP2 mRNA

NCBI chr X:46,837,043...46,882,358
Ensembl chr X:46,837,043...46,882,358

G

ribonuclease P/MRP subunit p14

decreases expression

alpha phellandrene results in decreased expression of RPP14 mRNA

NCBI chr 3:58,306,245...58,320,193
Ensembl chr 3:58,306,245...58,324,695

G

ribonuclease P/MRP subunit p38

decreases expression

alpha phellandrene results in decreased expression of RPP38 mRNA

NCBI chr10:15,097,355...15,104,257
Ensembl chr10:15,097,180...15,139,818

G

ribosomal protein S12

decreases expression

alpha phellandrene results in decreased expression of RPS12 mRNA

NCBI chr 6:132,814,569...132,817,564
Ensembl chr 6:132,814,569...132,817,564

G

RAS related

increases expression

alpha phellandrene results in increased expression of RRAS mRNA

NCBI chr19:49,635,292...49,640,143
Ensembl chr19:49,635,292...49,640,143

G

ribosomal RNA processing 12 homolog

decreases expression

alpha phellandrene results in decreased expression of RRP12 mRNA

NCBI chr10:97,356,357...97,401,370
Ensembl chr10:97,356,357...97,426,076

G

ribosomal RNA processing 15 homolog

decreases expression

alpha phellandrene results in decreased expression of RRP15 mRNA

NCBI chr 1:218,285,293...218,337,983
Ensembl chr 1:218,285,293...218,337,983

G

radical S-adenosyl methionine domain containing 2

increases expression

alpha phellandrene results in increased expression of RSAD2 mRNA

NCBI chr 2:6,865,885...6,898,239
Ensembl chr 2:6,865,557...6,898,239

G

retrotransposon Gag like 1

decreases expression

alpha phellandrene results in decreased expression of RTL1 mRNA

NCBI chr14:100,879,753...100,903,722
Ensembl chr14:100,879,753...100,903,722

G

retrotransposon Gag like 8A

increases expression

alpha phellandrene results in increased expression of RTL8A mRNA

NCBI chr X:135,050,932...135,052,135
Ensembl chr X:135,050,932...135,052,196

G

receptor transporter protein 4

increases expression

alpha phellandrene results in increased expression of RTP4 mRNA

NCBI chr 3:187,368,385...187,372,076
Ensembl chr 3:187,368,385...187,372,076

G

rubicon like autophagy enhancer

increases expression

alpha phellandrene results in increased expression of RUBCNL mRNA

NCBI chr13:46,334,681...46,390,042
Ensembl chr13:46,334,681...46,438,190

G

SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1

increases expression

alpha phellandrene results in increased expression of SAMHD1 mRNA

NCBI chr20:36,889,773...36,951,708
Ensembl chr20:36,890,229...36,951,893

G

spermidine/spermine N1-acetyltransferase 1

increases expression

alpha phellandrene results in increased expression of SAT1 mRNA

NCBI chr X:23,783,173...23,786,210
Ensembl chr X:23,783,173...23,786,210

G

SDA1 domain containing 1

decreases expression

alpha phellandrene results in decreased expression of SDAD1 mRNA

NCBI chr 4:75,949,915...75,990,945
Ensembl chr 4:75,940,950...75,990,962

G

SEC14 like lipid binding 1

increases expression

alpha phellandrene results in increased expression of SEC14L1 mRNA

NCBI chr17:77,088,685...77,217,101
Ensembl chr17:77,088,749...77,217,101

G

selenium binding protein 1

increases expression

alpha phellandrene results in increased expression of SELENBP1 mRNA; alpha phellandrene results in increased expression of SELENBP2 mRNA

NCBI chr 1:151,364,304...151,372,705
Ensembl chr 1:151,364,304...151,372,707

G

semaphorin 3C

decreases expression

alpha phellandrene results in decreased expression of SEMA3C mRNA

NCBI chr 7:80,742,538...80,922,389
Ensembl chr 7:80,742,538...80,922,359

G

SUMO specific peptidase 2

decreases expression

alpha phellandrene results in decreased expression of SENP2 mRNA

NCBI chr 3:185,586,295...185,633,551
Ensembl chr 3:185,582,496...185,633,551

G

septin 8

increases expression

alpha phellandrene results in increased expression of SEPT8 mRNA

NCBI chr 5:132,750,819...132,780,083
Ensembl chr 5:132,750,819...132,807,241

G

SERTA domain containing 3

increases expression

alpha phellandrene results in increased expression of SERTAD3 mRNA

NCBI chr19:40,440,844...40,444,335
Ensembl chr19:40,440,844...40,444,335

G

SET nuclear proto-oncogene

decreases expression

alpha phellandrene results in decreased expression of SET mRNA

NCBI chr 9:128,683,424...128,696,396
Ensembl chr 9:128,683,424...128,696,400

G

stratifin

increases expression

alpha phellandrene results in increased expression of SFN protein

NCBI chr 1:26,863,149...26,864,456
Ensembl chr 1:26,863,149...26,864,456

G

SAGA complex associated factor 29

decreases expression

alpha phellandrene results in decreased expression of SGF29 mRNA

NCBI chr16:28,553,920...28,591,790
Ensembl chr16:28,553,915...28,591,790

G

shugoshin 2

increases expression

alpha phellandrene results in increased expression of SGO2A mRNA

NCBI chr 2:200,526,142...200,584,096
Ensembl chr 2:200,510,008...200,584,096

G

sigma non-opioid intracellular receptor 1

decreases expression

alpha phellandrene results in decreased expression of SIGMAR1 mRNA

NCBI chr 9:34,634,722...34,637,787
Ensembl chr 9:34,634,722...34,637,844

G

solute carrier family 1 member 5

decreases expression

alpha phellandrene results in decreased expression of SLC1A5 mRNA

NCBI chr19:46,774,883...46,788,594
Ensembl chr19:46,774,883...46,788,594

G

solute carrier family 35 member B1

decreases expression

alpha phellandrene results in decreased expression of SLC35B1 mRNA

NCBI chr17:49,700,943...49,708,197
Ensembl chr17:49,700,934...49,709,014

G

solute carrier family 35 member D1

decreases expression

alpha phellandrene results in decreased expression of SLC35D1 mRNA

NCBI chr 1:66,972,976...67,054,148
Ensembl chr 1:66,999,350...67,054,148

G

solute carrier family 44 member 1

increases expression

alpha phellandrene results in increased expression of SLC44A1 mRNA

NCBI chr 9:105,244,651...105,438,504
Ensembl chr 9:105,244,622...105,439,171

G

solute carrier family 44 member 3

increases expression

alpha phellandrene results in increased expression of SLC44A3 mRNA

NCBI chr 1:94,820,357...94,895,247
Ensembl chr 1:94,820,342...94,895,246

G

solute carrier family 7 member 1

decreases expression

alpha phellandrene results in decreased expression of SLC7A1 mRNA

NCBI chr13:29,509,414...29,595,688
Ensembl chr13:29,509,414...29,595,688

G

solute carrier family 7 member 11

decreases expression

alpha phellandrene results in decreased expression of SLC7A11 mRNA

NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349

G

solute carrier family 7 member 6

decreases expression

alpha phellandrene results in decreased expression of SLC7A6 mRNA

NCBI chr16:68,264,526...68,301,819
Ensembl chr16:68,264,516...68,301,823

G

schlafen family member 5

increases expression

alpha phellandrene results in increased expression of SLFN4 mRNA; alpha phellandrene results in increased expression of SLFN5 mRNA

NCBI chr17:35,243,072...35,273,655
Ensembl chr17:35,243,071...35,273,655

G

small integral membrane protein 14

increases expression

alpha phellandrene results in increased expression of SMIM14 mRNA

NCBI chr 4:39,546,336...39,638,865
Ensembl chr 4:39,546,336...39,638,902

G

spermine oxidase

increases expression

alpha phellandrene results in increased expression of SMOX mRNA

NCBI chr20:4,148,828...4,187,727
Ensembl chr20:4,120,980...4,187,747

G

small nucleolar RNA host gene 1

decreases expression

alpha phellandrene results in decreased expression of SNHG1 mRNA

NCBI chr11:62,851,978...62,855,885
Ensembl chr11:62,851,833...62,856,444

G

small nucleolar RNA host gene 20

decreases expression

alpha phellandrene results in decreased expression of SNHG20 mRNA

NCBI chr17:77,088,643...77,094,986
Ensembl chr17:77,086,716...77,099,902

G

small nucleolar RNA host gene 5

decreases expression

alpha phellandrene results in decreased expression of SNHG5 mRNA

NCBI chr 6:85,677,007...85,678,733
Ensembl chr 6:85,644,369...85,678,943

G

small nucleolar RNA, H/ACA box 20

decreases expression

alpha phellandrene results in decreased expression of SNORA20 mRNA

NCBI chr 6:159,780,250...159,780,381
Ensembl chr 6:159,780,250...159,780,381

G

small nucleolar RNA, H/ACA box 21

decreases expression

alpha phellandrene results in decreased expression of SNORA21 mRNA

NCBI chr17:38,852,863...38,852,995
Ensembl chr17:38,852,863...38,852,994

G

small nucleolar RNA, H/ACA box 26

decreases expression

alpha phellandrene results in decreased expression of SNORA26 mRNA

NCBI chr 4:52,713,249...52,713,370
Ensembl chr 4:52,713,249...52,713,370

G

small nucleolar RNA, H/ACA box 3A

decreases expression

alpha phellandrene results in decreased expression of SNORA3 mRNA

NCBI chr11:8,684,227...8,684,356
Ensembl chr11:8,684,227...8,684,356

G

small nucleolar RNA, H/ACA box 44

decreases expression

alpha phellandrene results in decreased expression of SNORA44 mRNA

NCBI chr 1:28,580,381...28,580,512
Ensembl chr 1:28,580,381...28,580,512

G

small nucleolar RNA, H/ACA box 61

decreases expression

alpha phellandrene results in decreased expression of SNORA61 mRNA

NCBI chr 1:28,579,764...28,579,893
Ensembl chr 1:28,579,764...28,579,893

G

small nucleolar RNA, H/ACA box 73A

decreases expression

alpha phellandrene results in decreased expression of SNORA73A mRNA

NCBI chr 1:28,507,365...28,507,571
Ensembl chr 1:28,507,366...28,507,571

G

small nucleolar RNA, H/ACA box 73B

decreases expression

alpha phellandrene results in decreased expression of SNORA73B mRNA

NCBI chr 1:28,508,558...28,508,762
Ensembl chr 1:28,508,559...28,508,762

G

small nucleolar RNA, H/ACA box 75

decreases expression

alpha phellandrene results in decreased expression of SNORA75 mRNA

NCBI chr 2:231,455,800...231,455,936
Ensembl chr 2:231,455,800...231,455,936

G

small nucleolar RNA, H/ACA box 7A

decreases expression

alpha phellandrene results in decreased expression of SNORA7A mRNA

NCBI chr 3:12,840,312...12,840,450
Ensembl chr 3:12,840,312...12,840,450

G

small nucleolar RNA, C/D box 22

decreases expression

alpha phellandrene results in decreased expression of SNORD22 mRNA

NCBI chr11:62,852,910...62,853,035
Ensembl chr11:62,852,910...62,853,035

G

small nucleolar RNA, C/D box 34

decreases expression

alpha phellandrene results in decreased expression of SNORD34 mRNA

NCBI chr19:49,490,907...49,490,972
Ensembl chr19:49,490,904...49,490,974

G

small nucleolar RNA, C/D box 47

decreases expression

alpha phellandrene results in decreased expression of SNORD47 mRNA

NCBI chr 1:173,864,369...173,864,445

G

small nucleolar RNA, C/D box 52

decreases expression

alpha phellandrene results in decreased expression of SNORD52 mRNA

NCBI chr 6:31,837,076...31,837,139
Ensembl chr 6:31,837,076...31,837,142

G

small nucleolar RNA, C/D box 68

decreases expression

alpha phellandrene results in decreased expression of SNORD68 mRNA

NCBI chr16:89,561,430...89,561,501
Ensembl chr16:89,561,434...89,561,517

G

small nucleolar RNA, C/D box 82

decreases expression

alpha phellandrene results in decreased expression of SNORD82 mRNA

NCBI chr 2:231,460,368...231,460,442
Ensembl chr 2:231,460,371...231,460,440

G

small nucleolar RNA, C/D box 87

decreases expression

alpha phellandrene results in decreased expression of SNORD87 mRNA

NCBI chr 8:66,922,474...66,922,549
Ensembl chr 8:66,922,467...66,922,555

G

small nucleolar RNA, C/D box 95

decreases expression

alpha phellandrene results in decreased expression of SNORD95 mRNA

NCBI chr 5:181,243,314...181,243,376
Ensembl chr 5:181,243,312...181,243,379

G

small nucleolar RNA, C/D box 96A

decreases expression

alpha phellandrene results in decreased expression of SNORD96A mRNA

NCBI chr 5:181,241,818...181,241,889
Ensembl chr 5:181,241,814...181,241,892

G

small nuclear ribonucleoprotein D2 polypeptide

decreases expression

alpha phellandrene results in decreased expression of SNRPD2 mRNA

NCBI chr19:45,687,454...45,692,316
Ensembl chr19:45,687,460...45,692,569

G

SP100 nuclear antigen

increases expression

alpha phellandrene results in increased expression of SP100 mRNA

NCBI chr 2:230,416,201...230,545,606
Ensembl chr 2:230,415,942...230,545,606

G

SP140 nuclear body protein

increases expression

alpha phellandrene results in increased expression of SP140 mRNA

NCBI chr 2:230,186,151...230,316,571
Ensembl chr 2:230,203,110...230,313,215

G

SPC25 component of NDC80 kinetochore complex

increases expression

alpha phellandrene results in increased expression of SPC25 mRNA

NCBI chr 2:168,861,521...168,890,430
Ensembl chr 2:168,834,132...168,913,371

G

sprouty related EVH1 domain containing 3

increases expression

alpha phellandrene results in increased expression of SPRED3 mRNA

NCBI chr19:38,388,697...38,399,587
Ensembl chr19:38,388,421...38,399,587

G

sorcin

increases expression

alpha phellandrene results in increased expression of SRI mRNA

NCBI chr 7:88,205,115...88,226,976
Ensembl chr 7:88,205,115...88,226,993

G

spermidine synthase

decreases expression

alpha phellandrene results in decreased expression of SRM mRNA

NCBI chr 1:11,054,589...11,060,018
Ensembl chr 1:11,054,584...11,060,020

G

serine racemase

increases expression

alpha phellandrene results in increased expression of SRR mRNA

NCBI chr17:2,303,378...2,325,264
Ensembl chr17:2,303,383...2,325,260

G

serine and arginine rich splicing factor 7

decreases expression

alpha phellandrene results in decreased expression of SRSF7 mRNA

NCBI chr 2:38,743,599...38,751,494
Ensembl chr 2:38,743,599...38,751,494

G

signal sequence receptor subunit 4

decreases expression

alpha phellandrene results in decreased expression of SSR4 mRNA

NCBI chr X:153,794,159...153,798,512
Ensembl chr X:153,793,516...153,798,499

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5

decreases expression

alpha phellandrene results in decreased expression of ST8SIA5 mRNA

NCBI chr18:46,667,821...46,757,053
Ensembl chr18:46,667,821...46,759,257

G

STARD3 N-terminal like

increases expression

alpha phellandrene results in increased expression of STARD3NL mRNA

NCBI chr 7:38,178,245...38,230,669
Ensembl chr 7:38,178,245...38,230,670

G

StAR related lipid transfer domain containing 5

increases expression

alpha phellandrene results in increased expression of STARD5 mRNA

NCBI chr15:81,309,053...81,324,141
Ensembl chr15:81,309,053...81,324,183

G

signal transducer and activator of transcription 1

increases expression

alpha phellandrene results in increased expression of STAT1 mRNA

NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960

G

signal transducer and activator of transcription 2

increases expression

alpha phellandrene results in increased expression of STAT2 mRNA

NCBI chr12:56,341,597...56,360,107
Ensembl chr12:56,341,597...56,360,203

G

Suv3 like RNA helicase

decreases expression

alpha phellandrene results in decreased expression of SUPV3L1 mRNA

NCBI chr10:69,180,234...69,209,093
Ensembl chr10:69,180,234...69,209,099

G

TATA-box binding protein associated factor, RNA polymerase I subunit D

decreases expression

alpha phellandrene results in decreased expression of TAF1D mRNA

NCBI chr11:93,730,194...93,741,495
Ensembl chr11:93,729,948...93,784,391

G

thromboxane A synthase 1

decreases expression

alpha phellandrene results in decreased expression of TBXAS1 mRNA

NCBI chr 7:139,778,242...140,020,293
Ensembl chr 7:139,777,051...140,020,325

G

transcription elongation factor A N-terminal and central domain containing

increases expression

alpha phellandrene results in increased expression of TCEANC mRNA

NCBI chr X:13,653,141...13,665,409
Ensembl chr X:13,653,112...13,681,964

G

t-complex 11 like 2

increases expression

alpha phellandrene results in increased expression of TCP11L2 mRNA

NCBI chr12:106,297,935...106,347,003
Ensembl chr12:106,301,929...106,347,538

G

tectonic family member 3

increases expression

alpha phellandrene results in increased expression of TCTN3 mRNA

NCBI chr10:95,663,401...95,693,927
Ensembl chr10:95,659,823...95,694,143

G

tudor domain containing 7

increases expression

alpha phellandrene results in increased expression of TDRD7 mRNA

NCBI chr 9:97,412,096...97,496,125
Ensembl chr 9:97,412,096...97,496,125

G

TEPSIN adaptor related protein complex 4 accessory protein

decreases expression

alpha phellandrene results in decreased expression of TEPSIN mRNA

NCBI chr17:81,228,277...81,239,055
Ensembl chr17:81,228,277...81,239,091

G

testis associated actin remodelling kinase 2

increases expression

alpha phellandrene results in increased expression of TESK2 mRNA

NCBI chr 1:45,343,883...45,491,163
Ensembl chr 1:45,343,883...45,491,163

G

transcription factor AP-4

decreases expression

alpha phellandrene results in decreased expression of TFAP4 mRNA

NCBI chr16:4,257,186...4,273,023
Ensembl chr16:4,257,186...4,273,075

G

tRNA-histidine guanylyltransferase 1 like

decreases expression

alpha phellandrene results in decreased expression of THG1L mRNA

NCBI chr 5:157,731,420...157,741,449
Ensembl chr 5:157,731,420...157,741,449

G

translocase of inner mitochondrial membrane 10

decreases expression

alpha phellandrene results in decreased expression of TIMM10 mRNA

NCBI chr11:57,528,464...57,530,754
Ensembl chr11:57,528,464...57,530,803

G

transmembrane protein 120A

decreases expression

alpha phellandrene results in decreased expression of TMEM120A mRNA

NCBI chr 7:75,986,831...75,994,595
Ensembl chr 7:75,986,831...75,994,656

G

transmembrane protein 97

decreases expression

alpha phellandrene results in decreased expression of TMEM97 mRNA

NCBI chr17:28,319,200...28,328,685
Ensembl chr17:28,319,200...28,328,685

G

thymosin beta 10

increases expression

alpha phellandrene results in increased expression of TMSB10 mRNA

NCBI chr 2:84,905,656...84,906,671
Ensembl chr 2:84,905,656...84,906,671

G

thymosin beta 4 X-linked

increases expression

alpha phellandrene results in increased expression of TMSB4X mRNA

NCBI chr X:12,975,110...12,977,223
Ensembl chr X:12,975,110...12,977,227

G

tumor protein p53

increases expression
decreases expression
increases phosphorylation
affects localization

alpha phellandrene results in increased expression of TRP53 protein modified form
alpha phellandrene results in decreased expression of TRP53 protein
alpha phellandrene results in increased phosphorylation of TRP53 protein
alpha phellandrene affects the localization of TP53 protein

PMID:24861204 PMID:25649747

NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546

G

tumor protein D52

increases expression

alpha phellandrene results in increased expression of TPD52 mRNA

NCBI chr 8:80,031,082...80,171,564
Ensembl chr 8:80,034,745...80,231,232

G

tropomyosin 4

increases expression

alpha phellandrene results in increased expression of TPM4 mRNA

NCBI chr19:16,067,538...16,103,002
Ensembl chr19:16,067,021...16,103,005

G

tripartite motif containing 21

increases expression

alpha phellandrene results in increased expression of TRIM21 mRNA

NCBI chr11:4,384,897...4,393,702
Ensembl chr11:4,384,897...4,393,702

G

tripartite motif containing 22

increases expression

alpha phellandrene results in increased expression of TRIM30A mRNA

NCBI chr11:5,689,790...5,710,863
Ensembl chr11:5,689,610...5,737,089

G

TSPO associated protein 1

increases expression

alpha phellandrene results in increased expression of TSPOAP1 mRNA

NCBI chr17:58,301,231...58,328,795
Ensembl chr17:58,301,228...58,328,795

G

TSR1 ribosome maturation factor

decreases expression

alpha phellandrene results in decreased expression of TSR1 mRNA

NCBI chr17:2,322,396...2,336,457
Ensembl chr17:2,322,396...2,336,657

G

thiosulfate sulfurtransferase like domain containing 3

increases expression

alpha phellandrene results in increased expression of TSTD3 mRNA

NCBI chr 6:99,521,049...99,587,775
Ensembl chr 6:99,520,976...99,589,899

G

tetratricopeptide repeat domain 27

decreases expression

alpha phellandrene results in decreased expression of TTC27 mRNA

NCBI chr 2:32,628,050...32,821,051
Ensembl chr 2:32,628,032...32,821,051

G

ubiquitin associated and SH3 domain containing A

decreases expression

alpha phellandrene results in decreased expression of UBASH3A mRNA

NCBI chr21:42,403,902...42,447,684
Ensembl chr21:42,403,447...42,447,684

G

ubiquitin conjugating enzyme E2 H

increases expression

alpha phellandrene results in increased expression of UBE2H mRNA

NCBI chr 7:129,830,732...129,952,960
Ensembl chr 7:129,830,732...129,952,960

G

URB2 ribosome biogenesis homolog

decreases expression

alpha phellandrene results in decreased expression of URB2 mRNA

NCBI chr 1:229,626,247...229,660,200
Ensembl chr 1:229,626,247...229,660,200

G

ubiquitin specific peptidase 18

increases expression

alpha phellandrene results in increased expression of USP18 mRNA

NCBI chr22:18,150,170...18,177,397
Ensembl chr22:18,149,843...18,177,397

G

ubiquitin specific peptidase 22

increases expression

alpha phellandrene results in increased expression of USP22 mRNA

NCBI chr17:20,999,596...21,043,419
Ensembl chr17:20,999,596...21,043,760

G

ubiquitin specific peptidase 36

decreases expression

alpha phellandrene results in decreased expression of USP36 mRNA

NCBI chr17:78,787,381...78,841,439
Ensembl chr17:78,787,381...78,841,441

G

UTP20 small subunit processome component

decreases expression

alpha phellandrene results in decreased expression of UTP20 mRNA

NCBI chr12:101,280,105...101,386,618
Ensembl chr12:101,280,105...101,386,618

G

WD repeat domain 12

decreases expression

alpha phellandrene results in decreased expression of WDR12 mRNA

NCBI chr 2:202,874,261...202,911,673
Ensembl chr 2:202,874,261...203,014,798

G

WD repeat domain 3

decreases expression

alpha phellandrene results in decreased expression of WDR3 mRNA

NCBI chr 1:117,929,739...117,966,543
Ensembl chr 1:117,929,720...117,966,543

G

WD repeat domain 74

decreases expression

alpha phellandrene results in decreased expression of WDR74 mRNA

NCBI chr11:62,832,905...62,841,809
Ensembl chr11:62,832,342...62,841,809

G

WD repeat domain 75

decreases expression

alpha phellandrene results in decreased expression of WDR75 mRNA

NCBI chr 2:189,441,474...189,475,552
Ensembl chr 2:189,441,446...189,475,552

G

WD repeat, sterile alpha motif and U-box domain containing 1

increases expression

alpha phellandrene results in increased expression of WDSUB1 mRNA

NCBI chr 2:159,235,798...159,286,703
Ensembl chr 2:159,235,798...159,286,703

G

WD repeat domain, phosphoinositide interacting 1

increases expression

alpha phellandrene results in increased expression of WIPI1 mRNA

NCBI chr17:68,421,281...68,457,496
Ensembl chr17:68,420,948...68,457,513

G

XIAP associated factor 1

increases expression

alpha phellandrene results in increased expression of XAF1 mRNA

NCBI chr17:6,755,447...6,775,647
Ensembl chr17:6,755,447...6,775,647

G

tyrosyl-tRNA synthetase 2

decreases expression

alpha phellandrene results in decreased expression of YARS2 mRNA

NCBI chr12:32,746,544...32,755,897
Ensembl chr12:32,727,490...32,755,897

G

Z-DNA binding protein 1

increases expression

alpha phellandrene results in increased expression of ZBP1 mRNA

NCBI chr20:57,603,852...57,620,426
Ensembl chr20:57,603,846...57,620,576

G

ZNFX1 antisense RNA 1

decreases expression

alpha phellandrene results in decreased expression of ZFAS1 mRNA

NCBI chr20:49,278,178...49,289,260
Ensembl chr20:49,277,054...49,299,600

G

zinc finger protein 260

increases expression

alpha phellandrene results in increased expression of ZFP260 mRNA

NCBI chr19:36,510,687...36,528,271
Ensembl chr19:36,510,687...36,528,271

G

zinc finger protein 346

decreases expression

alpha phellandrene results in decreased expression of ZFP346 mRNA

NCBI chr 5:177,022,696...177,081,189
Ensembl chr 5:177,022,696...177,081,189

G

zinc finger protein 717

increases expression

alpha phellandrene results in increased expression of ZFP719 mRNA

NCBI chr 3:75,694,701...75,785,549
Ensembl chr 3:75,678,660...75,785,583

G

zinc finger protein 778

decreases expression

alpha phellandrene results in decreased expression of ZFP882 mRNA

NCBI chr16:89,217,703...89,237,141
Ensembl chr16:89,217,703...89,237,141

(S)-(-)-perillyl alcohol

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

BCL2 antagonist/killer 1

increases expression

perillyl alcohol results in increased expression of BAK1 protein

NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293

G

BCL2 associated X, apoptosis regulator

multiple interactions

perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of BAX protein]

NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798

G

BCL2 apoptosis regulator

multiple interactions

perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein]

NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128

G

catalase

multiple interactions

perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased activity of CAT protein]
perillyl alcohol inhibits the reaction [Ethanol results in decreased activity of CAT protein]

PMID:19161993 PMID:20923693

NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060

G

cyclin A2

decreases expression

perillyl alcohol results in decreased expression of CCNA2 protein

NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883

G

cyclin B1

decreases expression

perillyl alcohol results in decreased expression of CCNB1 protein

NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245

G

cyclin dependent kinase 2

multiple interactions
decreases expression

perillyl alcohol promotes the reaction [CDKN1A protein binds to and results in decreased activity of CDK2 protein]; perillyl alcohol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein]
perillyl alcohol results in decreased expression of CDK2 protein

NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789

G

cyclin dependent kinase inhibitor 1A

multiple interactions
increases response to substance
increases expression

perillyl alcohol promotes the reaction [CDKN1A protein binds to and results in decreased activity of CDK2 protein]
CDKN1A protein results in increased susceptibility to perillyl alcohol
perillyl alcohol results in increased expression of CDKN1A protein

NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397

G

cyclin dependent kinase inhibitor 1B

multiple interactions
increases response to substance
increases expression

perillyl alcohol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein]
CDKN1B protein results in increased susceptibility to perillyl alcohol
perillyl alcohol results in increased expression of CDKN1B protein

NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369

G

F-box protein 32

increases expression

perillyl alcohol results in increased expression of FBXO32 mRNA; perillyl alcohol results in increased expression of FBXO32 protein

NCBI chr 8:123,497,889...123,541,206
Ensembl chr 8:123,497,889...123,541,206

G

farnesyltransferase, CAAX box, subunit alpha

multiple interactions

[Vitamin A co-treated with perillyl alcohol] results in decreased expression of FNTA protein

NCBI chr 8:43,056,323...43,085,785
Ensembl chr 8:43,034,194...43,085,788

G

farnesyltransferase, CAAX box, subunit beta

multiple interactions
increases expression
decreases expression

[perillyl alcohol co-treated with Vitamin A] results in decreased expression of FNTB mRNA
perillyl alcohol results in increased expression of FNTB protein
perillyl alcohol results in decreased expression of FNTB mRNA

NCBI chr14:64,986,895...65,062,650
Ensembl chr14:64,986,895...65,062,652

G

glutathione-disulfide reductase

multiple interactions

perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of GSR protein]
perillyl alcohol inhibits the reaction [Ethanol results in decreased activity of GSR protein]

PMID:19161993 PMID:20923693

NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846

G

hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase

multiple interactions

perillyl alcohol inhibits the reaction [Ethanol results in decreased activity of H6PD protein]

NCBI chr 1:9,234,774...9,271,337
Ensembl chr 1:9,234,774...9,271,337

G

involucrin

decreases expression

perillyl alcohol results in decreased expression of IVL protein

NCBI chr 1:152,908,546...152,911,886
Ensembl chr 1:152,908,546...152,911,886

G

mitogen-activated protein kinase 1

multiple interactions

perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein]

NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680

G

mitogen-activated protein kinase 3

multiple interactions

perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein]

NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506

G

ornithine decarboxylase 1

multiple interactions

perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of ODC1 protein]

NCBI chr 2:10,439,968...10,448,327
Ensembl chr 2:10,439,968...10,448,327

G

Raf-1 proto-oncogene, serine/threonine kinase

multiple interactions

perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of RAF1 protein]

NCBI chr 3:12,583,601...12,664,117
Ensembl chr 3:12,582,101...12,664,201

G

RAP1A, member of RAS oncogene family

multiple interactions
increases expression

Mevalonic Acid affects the reaction [perillyl alcohol results in increased expression of RAP1A protein]

NCBI chr 1:111,542,009...111,716,691
Ensembl chr 1:111,542,218...111,716,691

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

perillyl alcohol inhibits the reaction [Ethanol results in increased activity of RELA protein]

NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090

G

ras homolog family member A

multiple interactions
increases expression

Mevalonic Acid affects the reaction [perillyl alcohol results in increased expression of RHOA protein]
[perillyl alcohol co-treated with Vitamin A] results in increased expression of RHOA mRNA

PMID:12671036 PMID:15959631

NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998

G

ras homolog family member B

multiple interactions
increases expression

Mevalonic Acid affects the reaction [perillyl alcohol results in increased expression of RHOB protein]
perillyl alcohol results in increased expression of RHOB mRNA; perillyl alcohol results in increased expression of RHOB protein
[perillyl alcohol co-treated with Vitamin A] affects the expression of RHOB mRNA; [perillyl alcohol co-treated with Vitamin A] affects the expression of RHOB protein

PMID:12671036 PMID:15959631

NCBI chr 2:20,447,074...20,449,440
Ensembl chr 2:20,447,074...20,449,440

G

tumor necrosis factor

multiple interactions

perillyl alcohol inhibits the reaction [Ethanol results in increased expression of TNF protein]

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

1,8-cineole

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

acetyl-CoA carboxylase alpha

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACACA mRNA

NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836

G

acetyl-CoA carboxylase beta

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of ACACB mRNA

NCBI chr12:109,111,189...109,268,226
Ensembl chr12:109,116,587...109,268,226

G

ATP citrate lyase

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA

NCBI chr17:41,866,917...41,930,545
Ensembl chr17:41,866,917...41,930,542

G

actin alpha 2, smooth muscle

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACTA2 mRNA

NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,934,822...88,991,339

G

actin related protein 2

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in decreased expression of ACTR2 protein]

NCBI chr 2:65,227,831...65,271,253
Ensembl chr 2:65,227,788...65,271,253

G

aryl hydrocarbon receptor

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of AHR mRNA

NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152

G

AKT serine/threonine kinase 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of AKT1 mRNA

NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759

G

ankyrin repeat domain 17

decreases expression

Eucalyptol results in decreased expression of ANKRD17 mRNA

NCBI chr 4:73,073,376...73,258,798
Ensembl chr 4:73,073,376...73,258,798

G

APC regulator of WNT signaling pathway

increases expression

Eucalyptol results in increased expression of APC mRNA

NCBI chr 5:112,707,498...112,846,239
Ensembl chr 5:112,707,518...112,846,239

G

achaete-scute family bHLH transcription factor 1

decreases expression

Eucalyptol results in decreased expression of ASCL1 mRNA

NCBI chr12:102,957,674...102,960,513
Ensembl chr12:102,957,674...102,960,513

G

BCL2 associated agonist of cell death

increases expression

Eucalyptol results in increased expression of BAD mRNA

NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704

G

catalase

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of CAT mRNA

NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060

G

cellular communication network factor 2

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of CTGF mRNA

NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372

G

cell division cycle 42

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in increased expression of CDC42 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of CDC42 protein]

NCBI chr 1:22,052,709...22,101,360
Ensembl chr 1:22,052,627...22,101,360

G

Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2

decreases expression

Eucalyptol results in decreased expression of CITED2 mRNA

NCBI chr 6:139,371,807...139,374,648
Ensembl chr 6:139,371,807...139,374,648

G

collagen type I alpha 1 chain

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of COL1A1 mRNA

NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632

G

carnitine palmitoyltransferase 1A

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of CPT1A mRNA

NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410

G

carnitine palmitoyltransferase 2

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of CPT2 mRNA

NCBI chr 1:53,196,824...53,214,197
Ensembl chr 1:53,196,792...53,214,197

G

cathepsin D

increases expression
multiple interactions

Eucalyptol results in increased expression of CTSD mRNA
Fulvestrant inhibits the reaction [Eucalyptol results in increased expression of CTSD mRNA]

NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573

G

cortactin

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in decreased expression of CTTN protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of CTTN protein]

NCBI chr11:70,398,529...70,436,575
Ensembl chr11:70,398,404...70,436,584

G

C-X-C motif chemokine ligand 8

multiple interactions

Eucalyptol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA]

NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716

G

cytochrome P450 family 1 subfamily A member 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of CYP1A1 mRNA

NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536

G

cytochrome P450 family 2 subfamily B member 6

multiple interactions

Eucalyptol inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion]

NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398

G

cytochrome P450 family 3 subfamily A member 4

increases hydroxylation
multiple interactions

CYP3A4 protein results in increased hydroxylation of Eucalyptol
Eucalyptol inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam]

PMID:15715982 PMID:18385293

NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248

G

cytochrome P450 family 3 subfamily A member 5

increases hydroxylation

CYP3A5 protein results in increased hydroxylation of Eucalyptol

NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996

G

diacylglycerol O-acyltransferase 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of DGAT1 mRNA

NCBI chr 8:144,314,584...144,326,852
Ensembl chr 8:144,314,584...144,326,910

G

ezrin

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in decreased expression of EZR protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of EZR protein]

NCBI chr 6:158,765,748...158,819,368
Ensembl chr 6:158,765,741...158,819,368

G

fatty acid synthase

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of FASN mRNA

NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294

G

forkhead box O1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of FOXO1 mRNA

NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641

G

glutathione peroxidase 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of GPX1 mRNA

NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605

G

growth regulating estrogen receptor binding 1

multiple interactions
increases expression

Fulvestrant inhibits the reaction [Eucalyptol results in increased expression of GREB1 mRNA]

NCBI chr 2:11,482,888...11,642,788
Ensembl chr 2:11,482,341...11,642,788

G

glycogen synthase kinase 3 beta

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in increased expression of GSK3B protein]; RHOA protein inhibits the reaction [Eucalyptol inhibits the reaction [Glucose results in increased expression of GSK3B protein]]

NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994

G

glutathione-disulfide reductase

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of GSR mRNA

NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846

G

3-hydroxy-3-methylglutaryl-CoA reductase

decreases expression

Eucalyptol results in decreased expression of HMGCR protein

NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001

G

intercellular adhesion molecule 1

multiple interactions

Eucalyptol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ICAM1 mRNA]; Eucalyptol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ICAM1 protein]

NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615

G

interleukin 1 beta

multiple interactions

[Ibuprofen co-treated with Eucalyptol] inhibits the reaction [ammonium acetate results in increased expression of IL1B mRNA]; Eucalyptol inhibits the reaction [ammonium acetate results in increased expression of IL1B mRNA]

NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816

G

interleukin 6

multiple interactions

[Ibuprofen co-treated with Eucalyptol] inhibits the reaction [ammonium acetate results in increased expression of IL6 mRNA]; Eucalyptol inhibits the reaction [ammonium acetate results in increased expression of IL6 mRNA]; Eucalyptol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of IL6 protein]

PMID:29789401 PMID:36346500

NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002

G

lymphoid enhancer binding factor 1

decreases expression

Eucalyptol results in decreased expression of LEF1 mRNA

NCBI chr 4:108,047,548...108,168,932
Ensembl chr 4:108,047,545...108,168,956

G

leptin

multiple interactions

Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of CTTN protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of EZR protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of PTK2 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of SRC protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of SYNPO protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of TLN1 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of VCL protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased abundance of Blood Glucose]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of CDC42 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of PXN protein modified form]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of RAC1 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of RHOA protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of ROCK1 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of VCL protein modified form]

NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629

G

mitogen-activated protein kinase 8

multiple interactions

Eucalyptol inhibits the reaction [Lipopolysaccharides results in decreased expression of and results in decreased phosphorylation of MAPK8 protein]

NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360

G

mitogen-activated protein kinase 9

multiple interactions

Eucalyptol inhibits the reaction [Lipopolysaccharides results in decreased expression of and results in decreased phosphorylation of MAPK9 protein]

NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099

G

malonyl-CoA decarboxylase

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of MLYCD mRNA

NCBI chr16:83,899,115...83,927,031
Ensembl chr16:83,899,115...83,951,445

G

mucin 19, oligomeric (gene/pseudogene)

decreases expression

Eucalyptol results in decreased expression of MUC19 mRNA

NCBI chr12:40,393,394...40,570,757
Ensembl chr12:40,393,395...40,570,832

G

mucin 2, oligomeric mucus/gel-forming

multiple interactions

Eucalyptol inhibits the reaction [Lipopolysaccharides results in increased expression of MUC2 mRNA]

NCBI chr11:1,074,874...1,110,508
Ensembl chr11:1,074,875...1,110,511

G

mucin 5AC, oligomeric mucus/gel-forming

multiple interactions

Eucalyptol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of MUC5AC mRNA]; Eucalyptol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of MUC5AC protein]

NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138

G

MYC proto-oncogene, bHLH transcription factor

decreases expression

Eucalyptol results in decreased expression of MYC mRNA

NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951

G

NFE2 like bZIP transcription factor 2

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of NFE2L2 mRNA

NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756

G

nuclear factor kappa B subunit 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of NFKB1 mRNA

NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302

G

NFKB inhibitor alpha

multiple interactions

Eucalyptol inhibits the reaction [Lipopolysaccharides affects the expression of NFKBIA protein]; Eucalyptol inhibits the reaction [Lipopolysaccharides inhibits the reaction [RELA protein binds to NFKBIA protein]]

NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749

G

nuclear receptor subfamily 4 group A member 3

decreases expression

Eucalyptol results in decreased expression of NR4A3 mRNA

NCBI chr 9:99,821,885...99,866,891
Ensembl chr 9:99,821,855...99,866,891

G

platelet derived growth factor receptor beta

decreases expression

Eucalyptol results in decreased expression of PDGFRB mRNA

NCBI chr 5:150,113,839...150,155,845
Ensembl chr 5:150,113,839...150,155,872

G

peroxisome proliferator activated receptor alpha

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of PPARA mRNA

NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755

G

prostaglandin-endoperoxide synthase 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of PTGS1 mRNA

NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703

G

protein tyrosine kinase 2

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in decreased expression of PTK2 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of PTK2 protein]

NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216

G

protein tyrosine kinase 6

decreases expression

Eucalyptol results in decreased expression of PTK6 mRNA

NCBI chr20:63,528,001...63,537,376
Ensembl chr20:63,528,001...63,537,376

G

paxillin

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [Glucose results in increased expression of PXN protein modified form]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of PXN protein modified form]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]]

NCBI chr12:120,210,447...120,265,730
Ensembl chr12:120,210,439...120,265,771

G

Rac family small GTPase 1

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in increased expression of RAC1 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of RAC1 protein]

NCBI chr 7:6,374,527...6,403,967
Ensembl chr 7:6,374,527...6,403,967

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

Eucalyptol inhibits the reaction [Lipopolysaccharides inhibits the reaction [RELA protein binds to NFKBIA protein]]

NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090

G

ras homolog family member A

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in increased expression of RHOA protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of RHOA protein]; RHOA protein inhibits the reaction [Eucalyptol inhibits the reaction [Glucose results in increased expression of GSK3B protein]]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of VCL protein]]

NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998

G

Rho associated coiled-coil containing protein kinase 1

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in increased expression of ROCK1 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of ROCK1 protein]

NCBI chr18:20,946,906...21,111,813
Ensembl chr18:20,944,612...21,111,813

G

SEC14 like lipid binding 2

multiple interactions

Eucalyptol inhibits the reaction [Testosterone results in increased expression of SEC14L2 mRNA]

NCBI chr22:30,397,018...30,425,303
Ensembl chr22:30,396,941...30,425,303

G

snail family transcriptional repressor 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of SNAI1 mRNA

NCBI chr20:49,982,980...49,988,886
Ensembl chr20:49,982,980...49,988,886

G

superoxide dismutase 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of SOD1 mRNA

NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931

G

SRC proto-oncogene, non-receptor tyrosine kinase

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in decreased expression of SRC protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of SRC protein]

NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,685...37,406,050

G

synaptopodin

multiple interactions

Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of SYNPO protein]

NCBI chr 5:150,586,010...150,659,207
Ensembl chr 5:150,601,080...150,659,207

G

T-box transcription factor 3

affects expression

Eucalyptol affects the expression of TBX3 mRNA

NCBI chr12:114,670,255...114,684,175
Ensembl chr12:114,670,255...114,684,175

G

transforming growth factor beta 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of TGFB1 mRNA

NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922

G

transglutaminase 1

decreases expression

Eucalyptol results in decreased expression of TGM1 mRNA

NCBI chr14:24,249,114...24,263,177
Ensembl chr14:24,249,114...24,264,432

G

talin 1

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in decreased expression of TLN1 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of TLN1 protein]

NCBI chr 9:35,696,948...35,732,195
Ensembl chr 9:35,696,948...35,732,195

G

tumor necrosis factor

multiple interactions

Eucalyptol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of TNF protein]
Eucalyptol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]

PMID:23872422 PMID:26207629 PMID:29789401

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

G

tripartite motif containing 21

decreases expression

Eucalyptol results in decreased expression of TRIM21 mRNA

NCBI chr11:4,384,897...4,393,702
Ensembl chr11:4,384,897...4,393,702

G

vinculin

multiple interactions

Eucalyptol inhibits the reaction [Glucose results in decreased expression of VCL protein]; Eucalyptol inhibits the reaction [Glucose results in increased expression of VCL protein modified form]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of VCL protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of VCL protein modified form]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of VCL protein]]

NCBI chr10:73,998,116...74,121,363
Ensembl chr10:73,995,193...74,121,363

G

zinc finger E-box binding homeobox 1

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of ZEB1 mRNA

NCBI chr10:31,318,417...31,529,804
Ensembl chr10:31,318,495...31,529,814

G

zinc finger E-box binding homeobox 2

multiple interactions

[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of ZEB2 mRNA

NCBI chr 2:144,384,081...144,520,119
Ensembl chr 2:144,364,364...144,521,057

4-terpineol

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cathepsin D

increases expression
multiple interactions

terpinenol-4 results in increased expression of CTSD mRNA
Fulvestrant inhibits the reaction [terpinenol-4 results in increased expression of CTSD mRNA]

NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573

G

cytochrome P450 family 4 subfamily F member 8

multiple interactions

terpinenol-4 inhibits the reaction [Testosterone results in increased expression of CYP4F8 mRNA]

NCBI chr19:15,615,218...15,630,639
Ensembl chr19:15,615,218...15,630,639

G

estrogen receptor 1

increases activity
multiple interactions

terpinenol-4 results in increased activity of ESR1 protein
NCOA2 protein promotes the reaction [terpinenol-4 results in increased activity of ESR1 protein]

NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619

G

growth regulating estrogen receptor binding 1

multiple interactions
increases expression

Fulvestrant inhibits the reaction [terpinenol-4 results in increased expression of GREB1 mRNA]

NCBI chr 2:11,482,888...11,642,788
Ensembl chr 2:11,482,341...11,642,788

G

nuclear receptor coactivator 2

multiple interactions

NCOA2 protein promotes the reaction [terpinenol-4 results in increased activity of ESR1 protein]

NCBI chr 8:70,109,782...70,456,446
Ensembl chr 8:70,109,782...70,403,808

G

progesterone receptor

increases expression
multiple interactions

terpinenol-4 results in increased expression of PGR mRNA
Fulvestrant inhibits the reaction [terpinenol-4 results in increased expression of PGR mRNA]

NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813

G

SEC14 like lipid binding 2

multiple interactions

terpinenol-4 inhibits the reaction [Testosterone results in increased expression of SEC14L2 mRNA]

NCBI chr22:30,397,018...30,425,303
Ensembl chr22:30,396,941...30,425,303

G

UDP glucuronosyltransferase family 2 member B28

multiple interactions

terpinenol-4 inhibits the reaction [Testosterone results in increased expression of UGT2B28 mRNA]

NCBI chr 4:69,280,475...69,295,050
Ensembl chr 4:69,280,475...69,295,050

alpha-phellandrene

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

apoptosis antagonizing transcription factor

decreases expression

alpha phellandrene results in decreased expression of AATF mRNA

NCBI chr17:36,948,954...37,056,871
Ensembl chr17:36,948,925...37,056,871

G

acid phosphatase 1

decreases expression

alpha phellandrene results in decreased expression of ACP1 mRNA

NCBI chr 2:264,947...278,283
Ensembl chr 2:264,140...278,283

G

acyl-CoA synthetase short chain family member 2

increases expression

alpha phellandrene results in increased expression of ACSS2 mRNA

NCBI chr20:34,874,989...34,927,959
Ensembl chr20:34,872,146...34,927,962

G

ADAM metallopeptidase domain 18

decreases expression

alpha phellandrene results in decreased expression of ADAM18 mRNA

NCBI chr 8:39,584,568...39,730,065
Ensembl chr 8:39,584,489...39,730,065

G

ADAM metallopeptidase domain 3A (pseudogene)

decreases expression

alpha phellandrene results in decreased expression of ADAM3 mRNA

NCBI chr 8:39,451,045...39,522,989
Ensembl chr 8:39,451,045...39,522,852
Ensembl chr 8:39,451,045...39,522,852

G

AFG2 AAA ATPase homolog A

decreases expression

alpha phellandrene results in decreased expression of AFG2A mRNA

NCBI chr 4:122,923,078...123,319,433
Ensembl chr 4:122,923,070...123,319,433

G

AKT serine/threonine kinase 1

decreases expression

alpha phellandrene results in decreased expression of AKT1 protein

NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759

G

aldehyde dehydrogenase 1 family member L2

increases expression

alpha phellandrene results in increased expression of ALDH1L2 mRNA

NCBI chr12:105,019,790...105,084,458
Ensembl chr12:105,019,784...105,107,643

G

aldolase, fructose-bisphosphate C

increases expression

alpha phellandrene results in increased expression of ALDOC mRNA

NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948

G

ankyrin repeat domain 49

decreases expression

alpha phellandrene results in decreased expression of ANKRD49 mRNA

NCBI chr11:94,493,984...94,499,578
Ensembl chr11:94,493,979...94,499,578

G

annexin A1

increases expression

alpha phellandrene results in increased expression of ANXA1 mRNA

NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,629

G

annexin A9

decreases expression

alpha phellandrene results in decreased expression of ANXA9 mRNA

NCBI chr 1:150,977,306...150,995,634
Ensembl chr 1:150,982,249...150,995,634

G

adaptor related protein complex 3 subunit mu 2

increases expression

alpha phellandrene results in increased expression of AP3M2 mRNA

NCBI chr 8:42,153,063...42,171,183
Ensembl chr 8:42,152,946...42,171,673

G

arginase 2

increases expression

alpha phellandrene results in increased expression of ARG2 mRNA

NCBI chr14:67,619,920...67,651,708
Ensembl chr14:67,619,920...67,651,708

G

Rho guanine nucleotide exchange factor 12

increases expression

alpha phellandrene results in increased expression of ARHGEF12 mRNA

NCBI chr11:120,336,413...120,489,937
Ensembl chr11:120,336,413...120,489,937

G

arylsulfatase family member K

decreases expression

alpha phellandrene results in decreased expression of ARSK mRNA

NCBI chr 5:95,555,101...95,605,102
Ensembl chr 5:95,555,101...95,605,102

G

aspartoacylase

increases expression

alpha phellandrene results in increased expression of ASPA mRNA

NCBI chr17:3,474,110...3,503,405
Ensembl chr17:3,472,374...3,503,405

G

activating transcription factor 3

increases expression

alpha phellandrene results in increased expression of ATF3 mRNA

NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777

G

BCL2 apoptosis regulator

increases phosphorylation

alpha phellandrene results in increased phosphorylation of BCL2 protein

NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128

G

beclin 1

increases phosphorylation

alpha phellandrene results in increased phosphorylation of BECN1 protein

NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350

G

Bcl2 modifying factor

increases expression

alpha phellandrene results in increased expression of BMF mRNA

NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892

G

BCL2 interacting protein 3

increases expression

alpha phellandrene results in increased expression of BNIP3 mRNA

NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967

G

biorientation of chromosomes in cell division 1

increases expression

alpha phellandrene results in increased expression of BOD1 mRNA

NCBI chr 5:173,607,145...173,616,650
Ensembl chr 5:173,607,145...173,616,659

G

BRCA1 DNA repair associated

decreases expression

alpha phellandrene results in decreased expression of BRCA1 protein

NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245

G

BTG anti-proliferation factor 2

increases expression

alpha phellandrene results in increased expression of BTG2 mRNA

NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602

G

C9orf72-SMCR8 complex subunit

increases expression

alpha phellandrene results in increased expression of C9ORF72 mRNA

NCBI chr 9:27,546,546...27,573,866
Ensembl chr 9:27,535,640...27,573,866

G

calmodulin 2

increases expression

alpha phellandrene results in increased expression of CALM2 mRNA

NCBI chr 2:47,160,082...47,176,936
Ensembl chr 2:47,160,084...47,176,921

G

calpain small subunit 1

increases expression

alpha phellandrene results in increased expression of CAPNS1 mRNA

NCBI chr19:36,140,066...36,150,353
Ensembl chr19:36,139,953...36,150,353

G

caprin family member 2

increases expression

alpha phellandrene results in increased expression of CAPRIN2 mRNA

NCBI chr12:30,709,553...30,754,951
Ensembl chr12:30,709,552...30,823,302

G

caspase recruitment domain family member 6

increases expression

alpha phellandrene results in increased expression of CARD6 mRNA

NCBI chr 5:40,841,367...40,855,354
Ensembl chr 5:40,841,308...40,860,175

G

calcium regulated heat stable protein 1

increases expression

alpha phellandrene results in increased expression of CARHSP1 mRNA

NCBI chr16:8,852,942...8,869,006
Ensembl chr16:8,852,942...8,869,012

G

C-C motif chemokine ligand 5

increases expression

alpha phellandrene results in increased expression of CCL5 mRNA

NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793

G

cyclin G2

increases expression

alpha phellandrene results in increased expression of CCNG2 mRNA

NCBI chr 4:77,157,207...77,170,060
Ensembl chr 4:77,157,207...77,433,388

G

C-C motif chemokine receptor like 2

increases expression

alpha phellandrene results in increased expression of CCRL2 mRNA

NCBI chr 3:46,407,259...46,409,523
Ensembl chr 3:46,407,166...46,412,997

G

CD59 molecule (CD59 blood group)

decreases expression

alpha phellandrene results in decreased expression of CD59A mRNA

NCBI chr11:33,703,010...33,736,479
Ensembl chr11:33,703,010...33,736,479

G

CUB domain containing protein 2

increases expression

alpha phellandrene results in increased expression of CDCP2 mRNA

NCBI chr 1:54,132,687...54,153,000
Ensembl chr 1:54,132,687...54,153,770

G

cyclin dependent kinase inhibitor 1A

increases expression

alpha phellandrene results in increased expression of CDKN1A mRNA

NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397

G

cyclin dependent kinase inhibitor 2D

increases expression

alpha phellandrene results in increased expression of CDKN2D mRNA

NCBI chr19:10,566,460...10,568,979
Ensembl chr19:10,566,460...10,569,059

G

CASP8 and FADD like apoptosis regulator

increases expression

alpha phellandrene results in increased expression of CFLAR mRNA

NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687

G

C-type lectin domain family 12 member A

decreases expression

alpha phellandrene results in decreased expression of CLEC12A mRNA

NCBI chr12:9,951,268...10,006,150
Ensembl chr12:9,951,316...9,995,694

G

C-type lectin domain family 4 member D

decreases expression

alpha phellandrene results in decreased expression of CLEC4D mRNA

NCBI chr12:8,513,503...8,531,696
Ensembl chr12:8,509,475...8,522,366

G

C-type lectin domain containing 6A

decreases expression

alpha phellandrene results in decreased expression of CLEC4N mRNA

NCBI chr12:8,455,962...8,478,330
Ensembl chr12:8,455,962...8,478,330

G

clustered mitochondria homolog

decreases expression

alpha phellandrene results in decreased expression of CLUH mRNA

NCBI chr17:2,689,387...2,712,020
Ensembl chr17:2,689,386...2,712,663

G

cytidine/uridine monophosphate kinase 2

increases expression

alpha phellandrene results in increased expression of CMPK2 mRNA

NCBI chr 2:6,840,553...6,866,635
Ensembl chr 2:6,840,570...6,866,635

G

complement C3b/C4b receptor 1 like

decreases expression

alpha phellandrene results in decreased expression of CR1L mRNA

NCBI chr 1:207,645,133...207,723,703
Ensembl chr 1:207,645,113...207,738,416

G

cysteine rich secretory protein 1

decreases expression

alpha phellandrene results in decreased expression of CRISP1 mRNA

NCBI chr 6:49,834,257...49,877,096
Ensembl chr 6:49,834,257...49,877,096

G

cystatin F

decreases expression

alpha phellandrene results in decreased expression of CST7 mRNA

NCBI chr20:24,949,269...24,959,928
Ensembl chr20:24,949,269...24,959,928

G

cystatin A

increases expression

alpha phellandrene results in increased expression of STFA1 mRNA

NCBI chr 3:122,325,248...122,341,969
Ensembl chr 3:122,325,248...122,341,969

G

cathepsin G

decreases expression

alpha phellandrene results in decreased expression of CTSG mRNA

NCBI chr14:24,573,518...24,576,250
Ensembl chr14:24,573,518...24,576,250

G

C-X-C motif chemokine ligand 10

increases expression

alpha phellandrene results in increased expression of CXCL10 mRNA

NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497

G

cytochrome b561 family member D2

decreases expression

alpha phellandrene results in decreased expression of CYB561D2 mRNA

NCBI chr 3:50,350,862...50,354,069
Ensembl chr 3:50,350,845...50,358,460

G

cytoplasmic FMR1 interacting protein 2

increases expression

alpha phellandrene results in increased expression of CYFIP2 mRNA

NCBI chr 5:157,266,123...157,395,594
Ensembl chr 5:157,266,079...157,395,595

G

cytochrome P450 family 51 subfamily A member 1

decreases expression

alpha phellandrene results in decreased expression of CYP51 mRNA

NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803

G

developing brain homeobox 1

increases expression

alpha phellandrene results in increased expression of DBX1 mRNA

NCBI chr11:20,156,155...20,160,475
Ensembl chr11:20,156,155...20,160,475

G

dCMP deaminase

decreases expression

alpha phellandrene results in decreased expression of DCTD mRNA

NCBI chr 4:182,890,091...182,917,611
Ensembl chr 4:182,890,060...182,917,936

G

DNA damage inducible transcript 4

increases expression

alpha phellandrene results in increased expression of DDIT4 mRNA

NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036

G

DEAD-box helicase 31

decreases expression

alpha phellandrene results in decreased expression of DDX31 mRNA

NCBI chr 9:132,592,997...132,669,983
Ensembl chr 9:132,592,997...132,670,401

G

DExD/H-box helicase 60

increases expression

alpha phellandrene results in increased expression of DDX60 mRNA

NCBI chr 4:168,216,294...168,325,979
Ensembl chr 4:168,216,291...168,318,883

G

DNA fragmentation factor subunit beta

increases expression

alpha phellandrene results in increased expression of DFFB mRNA

NCBI chr 1:3,857,476...3,885,429
Ensembl chr 1:3,857,267...3,885,429

G

diacylglycerol kinase alpha

increases expression

alpha phellandrene results in increased expression of DGKA mRNA

NCBI chr12:55,927,316...55,954,023
Ensembl chr12:55,927,319...55,954,027

G

dehydrogenase/reductase 1

increases expression

alpha phellandrene results in increased expression of DHRS1 mRNA

NCBI chr14:24,290,598...24,299,780
Ensembl chr14:24,290,598...24,299,780

G

DEAH-box helicase 33

decreases expression

alpha phellandrene results in decreased expression of DHX33 mRNA

NCBI chr17:5,440,917...5,468,982
Ensembl chr17:5,440,917...5,468,982

G

DExH-box helicase 58

increases expression

alpha phellandrene results in increased expression of DHX58 mRNA

NCBI chr17:42,101,411...42,112,714
Ensembl chr17:42,101,404...42,112,714

G

dyskerin pseudouridine synthase 1

decreases expression

alpha phellandrene results in decreased expression of DKC1 mRNA

NCBI chr X:154,762,864...154,777,689
Ensembl chr X:154,762,742...154,777,689

G

dual specificity phosphatase 1

increases expression

alpha phellandrene results in increased expression of DUSP1 mRNA

NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195

G

dual specificity phosphatase 6

increases expression

alpha phellandrene results in increased expression of DUSP6 mRNA

NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501

G

dynein light chain Tctex-type 3

increases expression

alpha phellandrene results in increased expression of DYNLT3 mRNA

NCBI chr X:37,838,836...37,847,571
Ensembl chr X:37,836,757...37,847,571

G

egl-9 family hypoxia inducible factor 3

increases expression

alpha phellandrene results in increased expression of EGLN3 mRNA

NCBI chr14:33,924,227...33,951,074
Ensembl chr14:33,924,227...34,462,774

G

early growth response 1

increases expression

alpha phellandrene results in increased expression of EGR1 mRNA

NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303

G

eukaryotic translation initiation factor 5

decreases expression

alpha phellandrene results in decreased expression of EIF5 mRNA

NCBI chr14:103,334,237...103,345,025
Ensembl chr14:103,333,544...103,345,025

G

elaC ribonuclease Z 2

decreases expression

alpha phellandrene results in decreased expression of ELAC2 mRNA

NCBI chr17:12,991,612...13,018,027
Ensembl chr17:12,991,612...13,018,065

G

ELOVL fatty acid elongase 1

decreases expression

alpha phellandrene results in decreased expression of ELOVL1 mRNA

NCBI chr 1:43,363,401...43,368,011
Ensembl chr 1:43,363,398...43,368,074

G

ELOVL fatty acid elongase 7

increases expression

alpha phellandrene results in increased expression of ELOVL7 mRNA

NCBI chr 5:60,751,791...60,844,269
Ensembl chr 5:60,751,791...60,844,274

G

enolase 2

increases expression

alpha phellandrene results in increased expression of ENO2 mRNA

NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698

G

F-box protein 44

increases expression

alpha phellandrene results in increased expression of FBXO44 mRNA

NCBI chr 1:11,654,407...11,663,327
Ensembl chr 1:11,654,375...11,663,327

G

FGGY carbohydrate kinase domain containing

increases expression

alpha phellandrene results in increased expression of FGGY mRNA

NCBI chr 1:59,296,378...59,762,730
Ensembl chr 1:59,296,638...59,810,647

G

FLVCR choline and heme transporter 1

decreases expression

alpha phellandrene results in decreased expression of FLVCR1 mRNA

NCBI chr 1:212,858,275...212,899,363
Ensembl chr 1:212,858,275...212,899,363

G

Fos proto-oncogene, AP-1 transcription factor subunit

increases expression

alpha phellandrene results in increased expression of FOS mRNA

NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190

G

forkhead box O1

increases expression

alpha phellandrene results in increased expression of FOXO1 mRNA

NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641

G

formyl peptide receptor 1

decreases expression

alpha phellandrene results in decreased expression of FPR1 mRNA

NCBI chr19:51,745,172...51,751,878
Ensembl chr19:51,745,172...51,804,115

G

ferritin heavy chain 1

increases expression

alpha phellandrene results in increased expression of FTH1 mRNA

NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634

G

ferritin light chain

increases expression

alpha phellandrene results in increased expression of FTL1 mRNA; alpha phellandrene results in increased expression of FTL2-PS mRNA

NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,967,896

G

FtsJ RNA 2'-O-methyltransferase 3

decreases expression

alpha phellandrene results in decreased expression of FTSJ3 mRNA

NCBI chr17:63,819,433...63,827,663
Ensembl chr17:63,819,433...63,830,012

G

frataxin

decreases expression

alpha phellandrene results in decreased expression of FXN mRNA

NCBI chr 9:69,035,752...69,079,076
Ensembl chr 9:69,035,751...69,079,076

G

GABA type A receptor-associated protein

increases expression

alpha phellandrene results in increased expression of GABARAP mRNA

NCBI chr17:7,240,008...7,242,449
Ensembl chr17:7,240,008...7,242,449

G

growth arrest and DNA damage inducible alpha

increases expression

alpha phellandrene results in increased expression of GADD45A mRNA

NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334

G

growth arrest specific 5

decreases expression

alpha phellandrene results in decreased expression of GAS5 mRNA

NCBI chr 1:173,863,901...173,869,045
Ensembl chr 1:173,851,424...173,868,940

G

guanylate binding protein family member 6

increases expression

alpha phellandrene results in increased expression of GBP6 mRNA

NCBI chr 1:89,364,059...89,388,160
Ensembl chr 1:89,364,059...89,388,160

G

GNAS complex locus

increases expression

alpha phellandrene results in increased expression of GNAS mRNA

NCBI chr20:58,839,748...58,911,192
Ensembl chr20:58,839,718...58,911,192

G

G protein nucleolar 3

decreases expression

alpha phellandrene results in decreased expression of GNL3 mRNA

NCBI chr 3:52,685,920...52,694,497
Ensembl chr 3:52,681,156...52,694,497

G

G protein-coupled receptor 84

decreases expression

alpha phellandrene results in decreased expression of GPR84 mRNA

NCBI chr12:54,350,698...54,364,486
Ensembl chr12:54,362,445...54,364,487

G

GREB1 like retinoic acid receptor coactivator

increases expression

alpha phellandrene results in increased expression of GREB1L mRNA

NCBI chr18:21,242,232...21,526,112
Ensembl chr18:21,242,232...21,526,112

G

glutamate ionotropic receptor NMDA type subunit associated protein 1

increases expression

alpha phellandrene results in increased expression of GRINA mRNA

NCBI chr 8:143,990,056...143,993,415
Ensembl chr 8:143,990,056...143,993,415

G

glycosyltransferase like domain containing 1

increases expression

alpha phellandrene results in increased expression of GTDC1 mRNA

NCBI chr 2:143,938,068...144,333,069
Ensembl chr 2:143,938,068...144,332,568

G

glycogen synthase 1

increases expression

alpha phellandrene results in increased expression of GYS1 mRNA

NCBI chr19:48,968,130...48,993,309
Ensembl chr19:48,968,130...48,993,310

G

granzyme H

decreases expression

alpha phellandrene results in decreased expression of GZME mRNA

NCBI chr14:24,606,480...24,609,685
Ensembl chr14:24,606,480...24,609,699

G

H1.0 linker histone

increases expression

alpha phellandrene results in increased expression of H1F0 mRNA

NCBI chr22:37,805,229...37,807,432
Ensembl chr22:37,805,229...37,807,432

G

H1.2 linker histone, cluster member

increases expression

alpha phellandrene results in increased expression of H1F2 mRNA

NCBI chr 6:26,055,740...26,056,470
Ensembl chr 6:26,054,760...26,056,470

G

H2B clustered histone 14

increases expression

alpha phellandrene results in increased expression of H2BC14 mRNA

NCBI chr 6:27,815,022...27,815,489
Ensembl chr 6:27,815,022...27,815,489

G

H2B clustered histone 18

increases expression

alpha phellandrene results in increased expression of H2BC18 mRNA

NCBI chr 1:149,782,689...149,812,370
Ensembl chr 1:149,782,689...149,812,373

G

H2B clustered histone 4

increases expression

alpha phellandrene results in increased expression of H2BC4 mRNA

NCBI chr 6:26,113,170...26,123,926
Ensembl chr 6:26,086,317...26,123,926

G

H3 clustered histone 4

increases expression

alpha phellandrene results in increased expression of H3C4 mRNA

NCBI chr 6:26,196,784...26,199,293
Ensembl chr 6:26,195,164...26,197,286

G

H4 clustered histone 4

increases expression

alpha phellandrene results in increased expression of H4C4 mRNA

NCBI chr 6:26,188,710...26,189,112
Ensembl chr 6:26,188,710...26,189,112

G

hydroxycarboxylic acid receptor 2

increases expression

alpha phellandrene results in increased expression of HCAR2 mRNA

NCBI chr12:122,701,293...122,703,357
Ensembl chr12:122,701,293...122,703,357

G

HEAT repeat containing 1

decreases expression

alpha phellandrene results in decreased expression of HEATR1 mRNA

NCBI chr 1:236,549,005...236,604,516
Ensembl chr 1:236,549,005...236,604,516

G

helicase with zinc finger 2

increases expression

alpha phellandrene results in increased expression of HELZ2 mRNA

NCBI chr20:63,558,086...63,574,239
Ensembl chr20:63,558,086...63,574,239

G

HGH1 homolog

decreases expression

alpha phellandrene results in decreased expression of BRP16 mRNA

NCBI chr 8:144,137,774...144,140,851
Ensembl chr 8:144,137,774...144,140,851

G

hypoxia inducible lipid droplet associated

increases expression

alpha phellandrene results in increased expression of HILPDA mRNA

NCBI chr 7:128,455,878...128,458,418
Ensembl chr 7:128,455,849...128,458,418

G

HIVEP zinc finger 3

increases expression

alpha phellandrene results in increased expression of HIVEP3 mRNA

NCBI chr 1:41,506,365...42,035,934
Ensembl chr 1:41,506,365...42,035,925

G

heat shock protein family A (Hsp70) member 2

increases expression

alpha phellandrene results in increased expression of HSPA2 mRNA

NCBI chr14:64,535,905...64,543,237
Ensembl chr14:64,535,905...64,546,173

G

heat shock protein family A (Hsp70) member 5

decreases expression

alpha phellandrene results in decreased expression of HSPA5 mRNA

NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382

G

heat shock protein family A (Hsp70) member 8

decreases expression

alpha phellandrene results in decreased expression of HSPA8 mRNA

NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230

G

inhibitor of DNA binding 2

increases expression

alpha phellandrene results in increased expression of ID2 mRNA

NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461

G

isopentenyl-diphosphate delta isomerase 1

decreases expression

alpha phellandrene results in decreased expression of IDI1 mRNA

NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119

G

interferon induced with helicase C domain 1

increases expression

alpha phellandrene results in increased expression of IFIH1 mRNA

NCBI chr 2:162,267,074...162,318,684
Ensembl chr 2:162,267,074...162,318,684

G

interferon induced protein with tetratricopeptide repeats 1

increases expression

alpha phellandrene results in increased expression of IFIT1 mRNA

NCBI chr10:89,392,623...89,406,487
Ensembl chr10:89,392,546...89,406,487

G

interferon lambda 3

increases expression

alpha phellandrene results in increased expression of IFNL3 mRNA

NCBI chr19:39,243,455...39,245,250
Ensembl chr19:39,243,455...39,245,250

G

interleukin 2 receptor subunit alpha

decreases expression

alpha phellandrene results in decreased expression of IL2RA mRNA

NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370

G

interleukin 36 gamma

decreases expression

alpha phellandrene results in decreased expression of IL36G mRNA

NCBI chr 2:112,978,006...112,985,658
Ensembl chr 2:112,973,203...112,985,658

G

interferon regulatory factor 5

increases expression

alpha phellandrene results in increased expression of IRF5 mRNA

NCBI chr 7:128,937,032...128,950,038
Ensembl chr 7:128,937,457...128,950,038

G

interferon regulatory factor 7

increases expression

alpha phellandrene results in increased expression of IRF7 mRNA

NCBI chr11:612,555...615,950
Ensembl chr11:612,553...615,983

G

immunity related GTPase M

increases expression

alpha phellandrene results in increased expression of IRGM2 mRNA

NCBI chr 5:150,846,521...150,902,402
Ensembl chr 5:150,846,521...150,900,736

G

integrin subunit alpha L

increases expression

alpha phellandrene results in increased expression of ITGAL mRNA

NCBI chr16:30,472,742...30,523,185
Ensembl chr16:30,472,658...30,523,567

G

jagunal homolog 1

decreases expression

alpha phellandrene results in decreased expression of JAGN1 mRNA

NCBI chr 3:9,890,610...9,894,349
Ensembl chr 3:9,890,574...9,894,349

G

Jun proto-oncogene, AP-1 transcription factor subunit

increases expression

alpha phellandrene results in increased expression of JUN mRNA

NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048

G

KN motif and ankyrin repeat domains 2

decreases expression

alpha phellandrene results in decreased expression of KANK2 mRNA

NCBI chr19:11,164,270...11,197,865
Ensembl chr19:11,164,270...11,197,791

G

lysine demethylase 7A

increases expression

alpha phellandrene results in increased expression of KDM7A mRNA

NCBI chr 7:140,084,746...140,176,983
Ensembl chr 7:140,084,746...140,176,983

G

kelch like family member 23

increases expression

alpha phellandrene results in increased expression of KLHL23 mRNA

NCBI chr 2:169,733,832...169,751,878
Ensembl chr 2:169,694,488...169,776,989

G

kelch like family member 24

increases expression

alpha phellandrene results in increased expression of KLHL24 mRNA

NCBI chr 3:183,635,623...183,684,519
Ensembl chr 3:183,635,610...183,684,519

G

LIM domain and actin binding 1

increases expression

alpha phellandrene results in increased expression of LIMA1 mRNA

NCBI chr12:50,175,788...50,283,520
Ensembl chr12:50,175,788...50,283,520

G

LLGL scribble cell polarity complex component 2

decreases expression

alpha phellandrene results in decreased expression of LLGL2 mRNA

NCBI chr17:75,525,002...75,575,209
Ensembl chr17:75,525,080...75,575,209

G

LIM domain containing preferred translocation partner in lipoma

increases expression

alpha phellandrene results in increased expression of LPP mRNA

NCBI chr 3:188,153,021...188,890,671
Ensembl chr 3:188,153,284...188,890,671

G

listerin E3 ubiquitin protein ligase 1

decreases expression

alpha phellandrene results in decreased expression of LTN1 mRNA

NCBI chr21:28,928,144...28,992,877
Ensembl chr21:28,928,144...28,992,956

G

lymphocyte antigen 6 family member H

decreases expression

alpha phellandrene results in decreased expression of LY6C1 mRNA; alpha phellandrene results in decreased expression of LY6C2 mRNA

NCBI chr 8:143,157,916...143,160,654
Ensembl chr 8:143,157,914...143,160,711

G

mitogen-activated protein kinase kinase 6

increases expression

alpha phellandrene results in increased expression of MAP2K6 mRNA

NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,697...69,553,865

G

methionine adenosyltransferase 2A

decreases expression

alpha phellandrene results in decreased expression of MAT2A mRNA

NCBI chr 2:85,539,168...85,545,281
Ensembl chr 2:85,539,168...85,545,281

G

mast cell expressed membrane protein 1

increases expression

alpha phellandrene results in increased expression of MCEMP1 mRNA

NCBI chr19:7,677,090...7,679,829
Ensembl chr19:7,677,088...7,679,829

G

mediator of DNA damage checkpoint 1

increases expression

alpha phellandrene results in increased expression of MDC1 protein

NCBI chr 6:30,699,807...30,717,281
Ensembl chr 6:30,699,807...30,717,447

G

midasin AAA ATPase 1

decreases expression

alpha phellandrene results in decreased expression of MDN1 mRNA

NCBI chr 6:89,642,498...89,819,794
Ensembl chr 6:89,642,498...89,819,794

G

mediator complex subunit 29

decreases expression

alpha phellandrene results in decreased expression of MED29 mRNA

NCBI chr19:39,391,378...39,400,641
Ensembl chr19:39,391,303...39,400,641

G

mediator complex subunit 31

increases expression

alpha phellandrene results in increased expression of MED31 mRNA

NCBI chr17:6,643,311...6,651,605
Ensembl chr17:6,643,311...6,651,634

G

mitochondria localized glutamic acid rich protein

increases expression

alpha phellandrene results in increased expression of MGARP mRNA

NCBI chr 4:139,266,165...139,280,225
Ensembl chr 4:139,266,165...139,280,225

G

alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase

decreases expression

alpha phellandrene results in decreased expression of MGAT2 mRNA

NCBI chr14:49,620,799...49,623,481
Ensembl chr14:49,620,799...49,623,481

G

O-6-methylguanine-DNA methyltransferase

decreases expression

alpha phellandrene results in decreased expression of MGMT protein

NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983

G

MINDY lysine 48 deubiquitinase 2

increases expression

alpha phellandrene results in increased expression of MINDY2 mRNA

NCBI chr15:58,771,302...58,861,900
Ensembl chr15:58,771,192...58,861,900

G

miR-17-92a-1 cluster host gene

decreases expression

alpha phellandrene results in decreased expression of MIR17HG mRNA

NCBI chr13:91,347,687...91,354,577
Ensembl chr13:91,347,686...91,397,592

G

microRNA 375

increases expression

alpha phellandrene results in increased expression of MIR375 mRNA

NCBI chr 2:219,001,645...219,001,708
Ensembl chr 2:219,001,645...219,001,708

G

major histocompatibility complex, class I-related

increases expression

alpha phellandrene results in increased expression of MR1 mRNA

NCBI chr 1:181,033,387...181,061,938
Ensembl chr 1:181,033,374...181,061,938

G

mitochondrial ribosomal protein L20

decreases expression

alpha phellandrene results in decreased expression of MRPL20 mRNA

NCBI chr 1:1,401,909...1,407,293
Ensembl chr 1:1,401,909...1,407,293

G

mitochondrial ribosomal protein L45

increases expression

alpha phellandrene results in increased expression of MRPL45 mRNA

NCBI chr17:38,297,168...38,323,211
Ensembl chr17:38,297,023...38,323,217

G

MRT4 homolog, ribosome maturation factor

decreases expression

alpha phellandrene results in decreased expression of MRTO4 mRNA

NCBI chr 1:19,251,805...19,260,128
Ensembl chr 1:19,251,805...19,260,128

G

membrane spanning 4-domains A3

decreases expression

alpha phellandrene results in decreased expression of MS4A3 mRNA

NCBI chr11:60,056,665...60,071,115
Ensembl chr11:60,056,587...60,071,115

G

mechanistic target of rapamycin kinase

decreases expression

alpha phellandrene results in decreased expression of MTOR protein

NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556

G

metaxin 3

decreases expression

alpha phellandrene results in decreased expression of MTX3 mRNA

NCBI chr 5:79,976,716...79,991,262
Ensembl chr 5:79,976,716...79,991,262

G

mucin 13, cell surface associated

decreases expression

alpha phellandrene results in decreased expression of MUC13 mRNA

NCBI chr 3:124,905,442...124,934,751
Ensembl chr 3:124,905,442...124,953,819

G

MX dynamin like GTPase 2

increases expression

alpha phellandrene results in increased expression of MX2 mRNA

NCBI chr21:41,362,027...41,409,393
Ensembl chr21:41,361,999...41,409,393

G

MAX dimerization protein 1

increases expression

alpha phellandrene results in increased expression of MXD1 mRNA

NCBI chr 2:69,915,109...69,942,945
Ensembl chr 2:69,897,688...69,942,945

G

myeloid associated differentiation marker

increases expression

alpha phellandrene results in increased expression of MYADM mRNA

NCBI chr19:53,865,628...53,876,435
Ensembl chr19:53,864,763...53,878,125

G

MYB binding protein 1a

decreases expression

alpha phellandrene results in decreased expression of MYBBP1A mRNA

NCBI chr17:4,538,904...4,555,384
Ensembl chr17:4,538,897...4,555,386

G

myosin IXA

increases expression

alpha phellandrene results in increased expression of MYO9A mRNA

NCBI chr15:71,822,291...72,118,600
Ensembl chr15:71,822,291...72,118,577

G

nicotinamide phosphoribosyltransferase

increases expression

alpha phellandrene results in increased expression of NAMPT mRNA

NCBI chr 7:106,248,298...106,285,888
Ensembl chr 7:106,248,298...106,285,966

G

N-acetyltransferase 10

decreases expression

alpha phellandrene results in decreased expression of NAT10 mRNA

NCBI chr11:34,105,629...34,146,908
Ensembl chr11:34,105,617...34,147,670

G

NDRG family member 2

increases expression

alpha phellandrene results in increased expression of NDRG2 mRNA

NCBI chr14:21,016,763...21,070,872
Ensembl chr14:21,016,763...21,070,872

G

nuclear factor, interleukin 3 regulated

increases expression

alpha phellandrene results in increased expression of NFIL3 mRNA

NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,408,748...91,424,626

G

NFKB inhibitor alpha

increases expression

alpha phellandrene results in increased expression of NFKBIA mRNA

NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749

G

NHP2 ribonucleoprotein

decreases expression

alpha phellandrene results in decreased expression of NHP2 mRNA

NCBI chr 5:178,149,463...178,153,885
Ensembl chr 5:178,149,463...178,153,894

G

nucleolar protein 10

decreases expression

alpha phellandrene results in decreased expression of NOL10 mRNA

NCBI chr 2:10,570,754...10,689,975
Ensembl chr 2:10,562,347...10,689,987

G

nucleolar protein 8

decreases expression

alpha phellandrene results in decreased expression of NOL8 mRNA

NCBI chr 9:92,297,358...92,325,350
Ensembl chr 9:92,297,358...92,325,636

G

nucleolar and coiled-body phosphoprotein 1

decreases expression

alpha phellandrene results in decreased expression of NOLC1 mRNA

NCBI chr10:102,152,389...102,163,870
Ensembl chr10:102,152,176...102,163,871

G

NOP2 nucleolar protein

decreases expression

alpha phellandrene results in decreased expression of NOP2 mRNA

NCBI chr12:6,556,871...6,568,291
Ensembl chr12:6,556,863...6,568,691

G

NOP56 ribonucleoprotein

decreases expression

alpha phellandrene results in decreased expression of NOP56 mRNA

NCBI chr20:2,652,632...2,658,393
Ensembl chr20:2,652,593...2,658,393

G

nitric oxide synthase 2

increases expression

alpha phellandrene results in increased expression of NOS2 mRNA

NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529

G

nuclear transport factor 2 like export factor 2

increases expression

alpha phellandrene results in increased expression of NXT2 mRNA

NCBI chr X:109,535,824...109,544,698
Ensembl chr X:109,535,781...109,544,698

G

2'-5'-oligoadenylate synthetase 1

increases expression

alpha phellandrene results in increased expression of OAS1A mRNA; alpha phellandrene results in increased expression of OAS1B mRNA

NCBI chr12:112,906,962...112,933,219
Ensembl chr12:112,905,856...112,933,219

G

2'-5'-oligoadenylate synthetase 3

increases expression

alpha phellandrene results in increased expression of OAS3 mRNA

NCBI chr12:112,938,474...112,973,251
Ensembl chr12:112,938,051...112,976,460

G

oxysterol binding protein like 9

increases expression

alpha phellandrene results in increased expression of OSBPL9 mRNA

NCBI chr 1:51,518,272...51,789,219
Ensembl chr 1:51,577,179...51,798,427

G

PABIR family member 2

increases expression

alpha phellandrene results in increased expression of PABIR2 mRNA

NCBI chr X:134,769,566...134,797,205
Ensembl chr X:134,769,566...134,797,232

G

poly(ADP-ribose) polymerase family member 14

increases expression

alpha phellandrene results in increased expression of PARP14 mRNA

NCBI chr 3:122,680,839...122,730,840
Ensembl chr 3:122,680,839...122,730,840

G

prenylcysteine oxidase 1 like

decreases expression

alpha phellandrene results in decreased expression of PCYOX1L mRNA

NCBI chr 5:149,358,046...149,369,653
Ensembl chr 5:149,358,037...149,369,653

G

phosphodiesterase 3B

increases expression

alpha phellandrene results in increased expression of PDE3B mRNA

NCBI chr11:14,643,804...14,899,321
Ensembl chr11:14,643,804...14,872,044

G

phosphoethanolamine/phosphocholine phosphatase 1

increases expression

alpha phellandrene results in increased expression of PHOSPHO1 mRNA

NCBI chr17:49,223,366...49,230,787
Ensembl chr17:49,223,366...49,230,787

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta

increases expression

alpha phellandrene results in increased expression of PIK3CB mRNA

NCBI chr 3:138,652,698...138,834,928
Ensembl chr 3:138,652,336...138,834,928

G

phospholipase D family member 4

increases expression

alpha phellandrene results in increased expression of PLD4 mRNA

NCBI chr14:104,924,879...104,937,785
Ensembl chr14:104,924,713...104,937,761

G

plexin domain containing 1

increases expression

alpha phellandrene results in increased expression of PLXDC1 mRNA

NCBI chr17:39,063,313...39,152,967
Ensembl chr17:39,063,313...39,154,394

G

proline rich nuclear receptor coactivator 2

increases expression

alpha phellandrene results in increased expression of PNRC2 mRNA

NCBI chr 1:23,959,164...23,963,462
Ensembl chr 1:23,956,839...23,963,462

G

RNA polymerase I subunit B

decreases expression

alpha phellandrene results in decreased expression of POLR1B mRNA

NCBI chr 2:112,542,036...112,579,818
Ensembl chr 2:112,541,915...112,579,818

G

POP1 homolog, ribonuclease P/MRP subunit

decreases expression

alpha phellandrene results in decreased expression of POP1 mRNA

NCBI chr 8:98,117,293...98,159,835
Ensembl chr 8:98,117,293...98,159,835

G

peter pan homolog

decreases expression

alpha phellandrene results in decreased expression of PPAN mRNA

NCBI chr19:10,106,223...10,112,012
Ensembl chr19:10,106,362...10,112,012

G

phosphoribosyl pyrophosphate amidotransferase

decreases expression

alpha phellandrene results in decreased expression of PPAT mRNA

NCBI chr 4:56,393,362...56,435,615
Ensembl chr 4:56,393,362...56,435,615

G

protein phosphatase, Mg2+/Mn2+ dependent 1K

increases expression

alpha phellandrene results in increased expression of PPM1K mRNA

NCBI chr 4:88,257,620...88,284,561
Ensembl chr 4:88,257,620...88,284,769

G

protein phosphatase 2 regulatory subunit B'gamma

increases expression

alpha phellandrene results in increased expression of PPP2R5C mRNA

NCBI chr14:101,760,573...101,927,992
Ensembl chr14:101,761,709...101,927,989

G

PPARG related coactivator 1

decreases expression

alpha phellandrene results in decreased expression of PPRC1 mRNA

NCBI chr10:102,119,889...102,150,333
Ensembl chr10:102,132,994...102,150,333

G

protein kinase, DNA-activated, catalytic subunit

decreases expression

alpha phellandrene results in decreased expression of PRKDC protein

NCBI chr 8:47,773,111...47,960,136
Ensembl chr 8:47,773,111...47,960,178

G

serine protease 1

decreases expression

alpha phellandrene results in decreased expression of TRY10 mRNA

NCBI chr 7:142,749,472...142,753,072
Ensembl chr 7:142,749,468...142,753,072

G

polypyrimidine tract binding protein 3

increases expression

alpha phellandrene results in increased expression of PTBP3 mRNA

NCBI chr 9:112,217,715...112,379,882
Ensembl chr 9:112,217,716...112,333,664

G

protein tyrosine phosphatase mitochondrial 1

decreases expression

alpha phellandrene results in decreased expression of PTPMT1 mRNA

NCBI chr11:47,565,599...47,573,461
Ensembl chr11:47,565,430...47,573,461

G

protein tyrosine phosphatase non-receptor type 7

decreases expression

alpha phellandrene results in decreased expression of PTPN7 mRNA

NCBI chr 1:202,147,013...202,161,588
Ensembl chr 1:202,147,012...202,161,588

G

pseudouridine synthase 7

decreases expression

alpha phellandrene results in decreased expression of PUS7 mRNA

NCBI chr 7:105,456,501...105,522,271
Ensembl chr 7:105,439,661...105,522,271

G

pseudouridine synthase 7 like

decreases expression

alpha phellandrene results in decreased expression of PUS7L mRNA

NCBI chr12:43,718,992...43,758,790
Ensembl chr12:43,718,992...43,758,793

G

RAD51 paralog C

increases expression

alpha phellandrene results in increased expression of RAD51C mRNA

NCBI chr17:58,692,573...58,735,611
Ensembl chr17:58,692,573...58,735,611

G

RAP2B, member of RAS oncogene family

increases expression

alpha phellandrene results in increased expression of RAP2B mRNA

NCBI chr 3:153,162,226...153,170,627
Ensembl chr 3:153,162,226...153,170,627

G

RNA binding motif protein 12B

decreases expression

alpha phellandrene results in decreased expression of RBM12B2 mRNA

NCBI chr 8:93,728,155...93,741,009
Ensembl chr 8:93,728,155...93,741,017

G

recombination signal binding protein for immunoglobulin kappa J region

increases expression

alpha phellandrene results in increased expression of RBPJ mRNA

NCBI chr 4:26,105,449...26,435,131
Ensembl chr 4:26,163,455...26,435,131

G

RNA terminal phosphate cyclase like 1

decreases expression

alpha phellandrene results in decreased expression of RCL1 mRNA

NCBI chr 9:4,792,944...4,861,066
Ensembl chr 9:4,792,944...4,885,917

G

Rho related BTB domain containing 2

increases expression

alpha phellandrene results in increased expression of RHOBTB2 mRNA

NCBI chr 8:22,950,813...23,020,199
Ensembl chr 8:22,987,417...23,020,509

G

RNA sensor RIG-I

increases expression

alpha phellandrene results in increased expression of RIGI mRNA

NCBI chr 9:32,455,302...32,526,196
Ensembl chr 9:32,455,302...32,526,348

G

ring finger protein 141

increases expression

alpha phellandrene results in increased expression of RNF141 mRNA

NCBI chr11:10,511,673...10,541,187
Ensembl chr11:10,511,673...10,541,230

G

ring finger protein 19B

increases expression

alpha phellandrene results in increased expression of RNF19B mRNA

NCBI chr 1:32,929,036...32,964,809
Ensembl chr 1:32,936,445...32,964,809

G

RP2 activator of ARL3 GTPase

increases expression

alpha phellandrene results in increased expression of RP2 mRNA

NCBI chr X:46,837,043...46,882,358
Ensembl chr X:46,837,043...46,882,358

G

ribonuclease P/MRP subunit p14

decreases expression

alpha phellandrene results in decreased expression of RPP14 mRNA

NCBI chr 3:58,306,245...58,320,193
Ensembl chr 3:58,306,245...58,324,695

G

ribonuclease P/MRP subunit p38

decreases expression

alpha phellandrene results in decreased expression of RPP38 mRNA

NCBI chr10:15,097,355...15,104,257
Ensembl chr10:15,097,180...15,139,818

G

ribosomal protein S12

decreases expression

alpha phellandrene results in decreased expression of RPS12 mRNA

NCBI chr 6:132,814,569...132,817,564
Ensembl chr 6:132,814,569...132,817,564

G

RAS related

increases expression

alpha phellandrene results in increased expression of RRAS mRNA

NCBI chr19:49,635,292...49,640,143
Ensembl chr19:49,635,292...49,640,143

G

ribosomal RNA processing 12 homolog

decreases expression

alpha phellandrene results in decreased expression of RRP12 mRNA

NCBI chr10:97,356,357...97,401,370
Ensembl chr10:97,356,357...97,426,076

G

ribosomal RNA processing 15 homolog

decreases expression

alpha phellandrene results in decreased expression of RRP15 mRNA

NCBI chr 1:218,285,293...218,337,983
Ensembl chr 1:218,285,293...218,337,983

G

radical S-adenosyl methionine domain containing 2

increases expression

alpha phellandrene results in increased expression of RSAD2 mRNA

NCBI chr 2:6,865,885...6,898,239
Ensembl chr 2:6,865,557...6,898,239

G

retrotransposon Gag like 1

decreases expression

alpha phellandrene results in decreased expression of RTL1 mRNA

NCBI chr14:100,879,753...100,903,722
Ensembl chr14:100,879,753...100,903,722

G

retrotransposon Gag like 8A

increases expression

alpha phellandrene results in increased expression of RTL8A mRNA

NCBI chr X:135,050,932...135,052,135
Ensembl chr X:135,050,932...135,052,196

G

receptor transporter protein 4

increases expression

alpha phellandrene results in increased expression of RTP4 mRNA

NCBI chr 3:187,368,385...187,372,076
Ensembl chr 3:187,368,385...187,372,076

G

rubicon like autophagy enhancer

increases expression

alpha phellandrene results in increased expression of RUBCNL mRNA

NCBI chr13:46,334,681...46,390,042
Ensembl chr13:46,334,681...46,438,190

G

SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1

increases expression

alpha phellandrene results in increased expression of SAMHD1 mRNA

NCBI chr20:36,889,773...36,951,708
Ensembl chr20:36,890,229...36,951,893

G

spermidine/spermine N1-acetyltransferase 1

increases expression

alpha phellandrene results in increased expression of SAT1 mRNA

NCBI chr X:23,783,173...23,786,210
Ensembl chr X:23,783,173...23,786,210

G

SDA1 domain containing 1

decreases expression

alpha phellandrene results in decreased expression of SDAD1 mRNA

NCBI chr 4:75,949,915...75,990,945
Ensembl chr 4:75,940,950...75,990,962

G

SEC14 like lipid binding 1

increases expression

alpha phellandrene results in increased expression of SEC14L1 mRNA

NCBI chr17:77,088,685...77,217,101
Ensembl chr17:77,088,749...77,217,101

G

selenium binding protein 1

increases expression

alpha phellandrene results in increased expression of SELENBP1 mRNA; alpha phellandrene results in increased expression of SELENBP2 mRNA

NCBI chr 1:151,364,304...151,372,705
Ensembl chr 1:151,364,304...151,372,707

G

semaphorin 3C

decreases expression

alpha phellandrene results in decreased expression of SEMA3C mRNA

NCBI chr 7:80,742,538...80,922,389
Ensembl chr 7:80,742,538...80,922,359

G

SUMO specific peptidase 2

decreases expression

alpha phellandrene results in decreased expression of SENP2 mRNA

NCBI chr 3:185,586,295...185,633,551
Ensembl chr 3:185,582,496...185,633,551

G

septin 8

increases expression

alpha phellandrene results in increased expression of SEPT8 mRNA

NCBI chr 5:132,750,819...132,780,083
Ensembl chr 5:132,750,819...132,807,241

G

SERTA domain containing 3

increases expression

alpha phellandrene results in increased expression of SERTAD3 mRNA

NCBI chr19:40,440,844...40,444,335
Ensembl chr19:40,440,844...40,444,335

G

SET nuclear proto-oncogene

decreases expression

alpha phellandrene results in decreased expression of SET mRNA

NCBI chr 9:128,683,424...128,696,396
Ensembl chr 9:128,683,424...128,696,400

G

stratifin

increases expression

alpha phellandrene results in increased expression of SFN protein

NCBI chr 1:26,863,149...26,864,456
Ensembl chr 1:26,863,149...26,864,456

G

SAGA complex associated factor 29

decreases expression

alpha phellandrene results in decreased expression of SGF29 mRNA

NCBI chr16:28,553,920...28,591,790
Ensembl chr16:28,553,915...28,591,790

G

shugoshin 2

increases expression

alpha phellandrene results in increased expression of SGO2A mRNA

NCBI chr 2:200,526,142...200,584,096
Ensembl chr 2:200,510,008...200,584,096

G

sigma non-opioid intracellular receptor 1

decreases expression

alpha phellandrene results in decreased expression of SIGMAR1 mRNA

NCBI chr 9:34,634,722...34,637,787
Ensembl chr 9:34,634,722...34,637,844

G

solute carrier family 1 member 5

decreases expression

alpha phellandrene results in decreased expression of SLC1A5 mRNA

NCBI chr19:46,774,883...46,788,594
Ensembl chr19:46,774,883...46,788,594

G

solute carrier family 35 member B1

decreases expression

alpha phellandrene results in decreased expression of SLC35B1 mRNA

NCBI chr17:49,700,943...49,708,197
Ensembl chr17:49,700,934...49,709,014

G

solute carrier family 35 member D1

decreases expression

alpha phellandrene results in decreased expression of SLC35D1 mRNA

NCBI chr 1:66,972,976...67,054,148
Ensembl chr 1:66,999,350...67,054,148

G

solute carrier family 44 member 1

increases expression

alpha phellandrene results in increased expression of SLC44A1 mRNA

NCBI chr 9:105,244,651...105,438,504
Ensembl chr 9:105,244,622...105,439,171

G

solute carrier family 44 member 3

increases expression

alpha phellandrene results in increased expression of SLC44A3 mRNA

NCBI chr 1:94,820,357...94,895,247
Ensembl chr 1:94,820,342...94,895,246

G

solute carrier family 7 member 1

decreases expression

alpha phellandrene results in decreased expression of SLC7A1 mRNA

NCBI chr13:29,509,414...29,595,688
Ensembl chr13:29,509,414...29,595,688

G

solute carrier family 7 member 11

decreases expression

alpha phellandrene results in decreased expression of SLC7A11 mRNA

NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349

G

solute carrier family 7 member 6

decreases expression

alpha phellandrene results in decreased expression of SLC7A6 mRNA

NCBI chr16:68,264,526...68,301,819
Ensembl chr16:68,264,516...68,301,823

G

schlafen family member 5

increases expression

alpha phellandrene results in increased expression of SLFN4 mRNA; alpha phellandrene results in increased expression of SLFN5 mRNA

NCBI chr17:35,243,072...35,273,655
Ensembl chr17:35,243,071...35,273,655

G

small integral membrane protein 14

increases expression

alpha phellandrene results in increased expression of SMIM14 mRNA

NCBI chr 4:39,546,336...39,638,865
Ensembl chr 4:39,546,336...39,638,902

G

spermine oxidase

increases expression

alpha phellandrene results in increased expression of SMOX mRNA

NCBI chr20:4,148,828...4,187,727
Ensembl chr20:4,120,980...4,187,747

G

small nucleolar RNA host gene 1

decreases expression

alpha phellandrene results in decreased expression of SNHG1 mRNA

NCBI chr11:62,851,978...62,855,885
Ensembl chr11:62,851,833...62,856,444

G

small nucleolar RNA host gene 20

decreases expression

alpha phellandrene results in decreased expression of SNHG20 mRNA

NCBI chr17:77,088,643...77,094,986
Ensembl chr17:77,086,716...77,099,902

G

small nucleolar RNA host gene 5

decreases expression

alpha phellandrene results in decreased expression of SNHG5 mRNA

NCBI chr 6:85,677,007...85,678,733
Ensembl chr 6:85,644,369...85,678,943

G

small nucleolar RNA, H/ACA box 20

decreases expression

alpha phellandrene results in decreased expression of SNORA20 mRNA

NCBI chr 6:159,780,250...159,780,381
Ensembl chr 6:159,780,250...159,780,381

G

small nucleolar RNA, H/ACA box 21

decreases expression

alpha phellandrene results in decreased expression of SNORA21 mRNA

NCBI chr17:38,852,863...38,852,995
Ensembl chr17:38,852,863...38,852,994

G

small nucleolar RNA, H/ACA box 26

decreases expression

alpha phellandrene results in decreased expression of SNORA26 mRNA

NCBI chr 4:52,713,249...52,713,370
Ensembl chr 4:52,713,249...52,713,370

G

small nucleolar RNA, H/ACA box 3A

decreases expression

alpha phellandrene results in decreased expression of SNORA3 mRNA

NCBI chr11:8,684,227...8,684,356
Ensembl chr11:8,684,227...8,684,356

G

small nucleolar RNA, H/ACA box 44

decreases expression

alpha phellandrene results in decreased expression of SNORA44 mRNA

NCBI chr 1:28,580,381...28,580,512
Ensembl chr 1:28,580,381...28,580,512

G

small nucleolar RNA, H/ACA box 61

decreases expression

alpha phellandrene results in decreased expression of SNORA61 mRNA

NCBI chr 1:28,579,764...28,579,893
Ensembl chr 1:28,579,764...28,579,893

G

small nucleolar RNA, H/ACA box 73A

decreases expression

alpha phellandrene results in decreased expression of SNORA73A mRNA

NCBI chr 1:28,507,365...28,507,571
Ensembl chr 1:28,507,366...28,507,571

G

small nucleolar RNA, H/ACA box 73B

decreases expression

alpha phellandrene results in decreased expression of SNORA73B mRNA

NCBI chr 1:28,508,558...28,508,762
Ensembl chr 1:28,508,559...28,508,762

G

small nucleolar RNA, H/ACA box 75

decreases expression

alpha phellandrene results in decreased expression of SNORA75 mRNA

NCBI chr 2:231,455,800...231,455,936
Ensembl chr 2:231,455,800...231,455,936

G

small nucleolar RNA, H/ACA box 7A

decreases expression

alpha phellandrene results in decreased expression of SNORA7A mRNA

NCBI chr 3:12,840,312...12,840,450
Ensembl chr 3:12,840,312...12,840,450

G

small nucleolar RNA, C/D box 22

decreases expression

alpha phellandrene results in decreased expression of SNORD22 mRNA

NCBI chr11:62,852,910...62,853,035
Ensembl chr11:62,852,910...62,853,035

G

small nucleolar RNA, C/D box 34

decreases expression

alpha phellandrene results in decreased expression of SNORD34 mRNA

NCBI chr19:49,490,907...49,490,972
Ensembl chr19:49,490,904...49,490,974

G

small nucleolar RNA, C/D box 47

decreases expression

alpha phellandrene results in decreased expression of SNORD47 mRNA

NCBI chr 1:173,864,369...173,864,445

G

small nucleolar RNA, C/D box 52

decreases expression

alpha phellandrene results in decreased expression of SNORD52 mRNA

NCBI chr 6:31,837,076...31,837,139
Ensembl chr 6:31,837,076...31,837,142

G

small nucleolar RNA, C/D box 68

decreases expression

alpha phellandrene results in decreased expression of SNORD68 mRNA

NCBI chr16:89,561,430...89,561,501
Ensembl chr16:89,561,434...89,561,517

G

small nucleolar RNA, C/D box 82

decreases expression

alpha phellandrene results in decreased expression of SNORD82 mRNA

NCBI chr 2:231,460,368...231,460,442
Ensembl chr 2:231,460,371...231,460,440

G

small nucleolar RNA, C/D box 87

decreases expression

alpha phellandrene results in decreased expression of SNORD87 mRNA

NCBI chr 8:66,922,474...66,922,549
Ensembl chr 8:66,922,467...66,922,555

G

small nucleolar RNA, C/D box 95

decreases expression

alpha phellandrene results in decreased expression of SNORD95 mRNA

NCBI chr 5:181,243,314...181,243,376
Ensembl chr 5:181,243,312...181,243,379

G

small nucleolar RNA, C/D box 96A

decreases expression

alpha phellandrene results in decreased expression of SNORD96A mRNA

NCBI chr 5:181,241,818...181,241,889
Ensembl chr 5:181,241,814...181,241,892

G

small nuclear ribonucleoprotein D2 polypeptide

decreases expression

alpha phellandrene results in decreased expression of SNRPD2 mRNA

NCBI chr19:45,687,454...45,692,316
Ensembl chr19:45,687,460...45,692,569

G

SP100 nuclear antigen

increases expression

alpha phellandrene results in increased expression of SP100 mRNA

NCBI chr 2:230,416,201...230,545,606
Ensembl chr 2:230,415,942...230,545,606

G

SP140 nuclear body protein

increases expression

alpha phellandrene results in increased expression of SP140 mRNA

NCBI chr 2:230,186,151...230,316,571
Ensembl chr 2:230,203,110...230,313,215

G

SPC25 component of NDC80 kinetochore complex

increases expression

alpha phellandrene results in increased expression of SPC25 mRNA

NCBI chr 2:168,861,521...168,890,430
Ensembl chr 2:168,834,132...168,913,371

G

sprouty related EVH1 domain containing 3

increases expression

alpha phellandrene results in increased expression of SPRED3 mRNA

NCBI chr19:38,388,697...38,399,587
Ensembl chr19:38,388,421...38,399,587

G

sorcin

increases expression

alpha phellandrene results in increased expression of SRI mRNA

NCBI chr 7:88,205,115...88,226,976
Ensembl chr 7:88,205,115...88,226,993

G

spermidine synthase

decreases expression

alpha phellandrene results in decreased expression of SRM mRNA

NCBI chr 1:11,054,589...11,060,018
Ensembl chr 1:11,054,584...11,060,020

G

serine racemase

increases expression

alpha phellandrene results in increased expression of SRR mRNA

NCBI chr17:2,303,378...2,325,264
Ensembl chr17:2,303,383...2,325,260

G

serine and arginine rich splicing factor 7

decreases expression

alpha phellandrene results in decreased expression of SRSF7 mRNA

NCBI chr 2:38,743,599...38,751,494
Ensembl chr 2:38,743,599...38,751,494

G

signal sequence receptor subunit 4

decreases expression

alpha phellandrene results in decreased expression of SSR4 mRNA

NCBI chr X:153,794,159...153,798,512
Ensembl chr X:153,793,516...153,798,499

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5

decreases expression

alpha phellandrene results in decreased expression of ST8SIA5 mRNA

NCBI chr18:46,667,821...46,757,053
Ensembl chr18:46,667,821...46,759,257

G

STARD3 N-terminal like

increases expression

alpha phellandrene results in increased expression of STARD3NL mRNA

NCBI chr 7:38,178,245...38,230,669
Ensembl chr 7:38,178,245...38,230,670

G

StAR related lipid transfer domain containing 5

increases expression

alpha phellandrene results in increased expression of STARD5 mRNA

NCBI chr15:81,309,053...81,324,141
Ensembl chr15:81,309,053...81,324,183

G

signal transducer and activator of transcription 1

increases expression

alpha phellandrene results in increased expression of STAT1 mRNA

NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960

G

signal transducer and activator of transcription 2

increases expression

alpha phellandrene results in increased expression of STAT2 mRNA

NCBI chr12:56,341,597...56,360,107
Ensembl chr12:56,341,597...56,360,203

G

Suv3 like RNA helicase

decreases expression

alpha phellandrene results in decreased expression of SUPV3L1 mRNA

NCBI chr10:69,180,234...69,209,093
Ensembl chr10:69,180,234...69,209,099

G

TATA-box binding protein associated factor, RNA polymerase I subunit D

decreases expression

alpha phellandrene results in decreased expression of TAF1D mRNA

NCBI chr11:93,730,194...93,741,495
Ensembl chr11:93,729,948...93,784,391

G

thromboxane A synthase 1

decreases expression

alpha phellandrene results in decreased expression of TBXAS1 mRNA

NCBI chr 7:139,778,242...140,020,293
Ensembl chr 7:139,777,051...140,020,325

G

transcription elongation factor A N-terminal and central domain containing

increases expression

alpha phellandrene results in increased expression of TCEANC mRNA

NCBI chr X:13,653,141...13,665,409
Ensembl chr X:13,653,112...13,681,964

G

t-complex 11 like 2

increases expression

alpha phellandrene results in increased expression of TCP11L2 mRNA

NCBI chr12:106,297,935...106,347,003
Ensembl chr12:106,301,929...106,347,538

G

tectonic family member 3

increases expression

alpha phellandrene results in increased expression of TCTN3 mRNA

NCBI chr10:95,663,401...95,693,927
Ensembl chr10:95,659,823...95,694,143

G

tudor domain containing 7

increases expression

alpha phellandrene results in increased expression of TDRD7 mRNA

NCBI chr 9:97,412,096...97,496,125
Ensembl chr 9:97,412,096...97,496,125

G

TEPSIN adaptor related protein complex 4 accessory protein

decreases expression

alpha phellandrene results in decreased expression of TEPSIN mRNA

NCBI chr17:81,228,277...81,239,055
Ensembl chr17:81,228,277...81,239,091

G

testis associated actin remodelling kinase 2

increases expression

alpha phellandrene results in increased expression of TESK2 mRNA

NCBI chr 1:45,343,883...45,491,163
Ensembl chr 1:45,343,883...45,491,163

G

transcription factor AP-4

decreases expression